Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3017766	p-c4	g/l (g/l)	7342	12026	0.28%
3017766	s-c4	g/l (g/l)	5461	8476	0.00%
3017766	p-c4	— (—)	702	914	100.00%	Distribution not available
3017766	s-c4	— (—)	407	531	100.00%	Distribution not available
3017766	s-komplementtic4	g/l (g/l)	7	7	0.00%	Distribution not available	Distribution not available
3017766	s-c4h	g/l (g/l)	7	7	0.00%	Distribution not available
3017766	p-c4d	mg/l (g/l)	6	6	0.00%
3017766	p-c4d	— (—)	5	5	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other interstitial pulmonary diseases

615

1147

5.87

318.02

1.8

1.4

0.23

0.24

g/l

2.94

590

1081

Systemic sclerosis

270

184

20.72

317.95

2.3

1.1

0.20

0.25

g/l

7.28

258

174

ILD, hospital admissions

613

1144

5.87

316.92

1.8

1.4

0.23

0.24

g/l

2.87

588

1078

Interstitial lung disease

615

1158

5.81

314.73

1.8

1.4

0.23

0.24

g/l

2.91

590

1091

Interstitial lung disease endpoints

615

1158

5.81

314.73

1.8

1.4

0.23

0.24

g/l

2.91

590

1091

Asthma, unspecified (mode), excluding more controls

1463

3857

3.08

309.92

1.6

0.24

0.23

g/l

2.39

1398

3654

Azathioprine

759

1161

7.21

307.65

4.0

1.4

0.20

0.24

g/l

14.39

732

1105

L04AA Selective immunosuppressants

1069

2388

4.91

307.65

3.6

1.6

0.22

0.24

g/l

8.53

1029

2259

Implicit bacterial Sepsis

1203

3098

3.73

307.65

1.9

1.5

0.24

0.23

g/l

1.31

1114

2925

L04AX Other immunosuppressants

2606

6398

4.38

307.65

2.6

1.5

0.22

0.24

g/l

21.19

2496

6062

Adverse effects, not elsewhere classified

993

2252

4.84

307.65

1.7

1.8

0.24

0.23

g/l

1.27

904

2143

Other necrotizing vasculopathies

489

468

12.57

307.65

2.7

1.2

0.24

0.25

g/l

0.58

465

441

SLE, strict definition

783

318

61.54

307.65

6.8

1.3

0.18

0.24

g/l

24.47

753

303

Headache

1916

5958

2.77

307.65

1.9

1.6

0.23

g/l

0.63

1810

5664

Autoimmune diseases excluding thyroid diseases

4376

5982

4.27

307.65

2.3

1.2

0.22

0.24

g/l

33.99

4174

5667

SLE (Finngen)

799

210

91.29

307.65

6.8

1.1

0.18

0.25

g/l

24.43

769

200

Dermatitis and eczema

3324

9378

2.39

307.65

1.9

1.7

0.23

g/l

2.79

3142

8905

Asthma (only as main-diagnosis), excluding more controls

2123

4287

3.04

307.65

1.6

1.7

0.24

0.23

g/l

2.47

2024

4070

Dyspnoea

2575

8535

2.38

307.65

1.8

1.7

0.24

0.23

g/l

0.86

2452

8082

Other respiratory diseases principally affecting the interstitium

704

1388

5.51

307.65

1.8

1.5

0.23

0.24

g/l

2.18

675

1314

Other and unspecified vasculitis limited to skin

291

184

23.81

307.65

1.8

1.5

0.24

0.23

g/l

0.19

279

177

Glomerular disorders in diseases classified elsewhere

741

933

9.27

307.65

3.4

1.4

0.25

0.24

g/l

2.15

701

879

Oedema, not elsewhere classified

1132

2555

4.68

307.65

1.7

1.6

0.24

0.23

g/l

1.73

1053

2407

Abnormalities of breathing

2774

6723

2.52

307.65

1.8

1.7

0.24

0.23

g/l

2.79

2643

6392

Fever of other and unknown origin

2173

4892

4.35

307.65

2.2

1.6

0.24

0.23

g/l

1.75

2061

4644

SLE, ICD10

783

318

61.54

307.65

6.8

1.3

0.18

0.24

g/l

24.47

753

303

Other specified/unspecified arthritis

1128

2411

5.02

307.65

1.8

1.6

0.23

0.24

g/l

1.39

1082

2275

Systemic lupus erythematosus, unspecified

713

280

69.85

307.65

6.9

1.3

0.18

0.24

g/l

22.57

684

267

Sicca syndrome [Sjögren]

995

691

19.96

307.65

2.6

1.2

0.20

0.25

g/l

28.89

963

656

Mixed connective tissue disease

995

613

26.36

307.65

3.5

1.5

0.19

0.24

g/l

21.17

965

577

Rheumatoid arthritis, including avohilmo

1325

4220

3.31

307.65

2.0

1.6

0.22

0.24

g/l

13.43

1256

3962

Oral corticosteroids

4886

6516

4.81

307.65

2.2

1.3

0.23

0.24

g/l

8.99

4640

6169

Urticaria

1242

3611

3.67

307.65

1.8

0.23

g/l

0.29

1163

3441

Other soft tissue disorders, not elsewhere classified

2918

7138

2.61

307.65

1.8

1.7

0.23

g/l

1.75

2780

6767

Finngen Rheumatological endpoints

3863

5695

4.05

307.65

2.4

1.2

0.22

0.24

g/l

28.31

3693

5388

Systemic lupus erythematosus

799

275

69.37

307.65

6.8

1.1

0.18

0.25

g/l

23.98

769

260

ILD medications

5104

6036

4.91

307.65

2.2

1.3

0.23

0.24

g/l

7.96

4863

5713

Seropositive rheumatoid arthritis

842

1846

4.81

307.65

2.0

1.2

0.21

0.25

g/l

20.65

801

1737

Heart failure, not strict

2200

5508

2.86

307.65

1.9

1.6

0.24

0.23

g/l

5.56

2089

5217

Arthropathies

2729

5649

2.52

307.65

1.9

1.7

0.23

g/l

1.39

2608

5362

2637

6954

2.44

307.65

1.9

1.6

0.24

0.23

g/l

2.17

2502

6601

Renal failure

1865

3242

5.68

307.65

1.8

1.5

0.26

0.23

g/l

18.98

1780

3038

ILD medications: prednisolone, methylprednisolone, prednisone

4944

5897

5.01

307.65

2.2

1.3

0.23

0.24

g/l

8.64

4703

5579

Chronic kidney disease

1387

2126

7.14

307.65

1.9

1.4

0.26

0.23

g/l

15.19

1325

1992

Used for control exclusion in common control thyroid runs

3465

5604

3.24

307.65

2.1

1.2

0.22

0.24

g/l

18.13

3301

5313

Bacterial infection, other or unspecified

1590

4498

3.33

307.65

1.8

1.5

0.24

0.23

g/l

4.38

1487

4253

Lupus erythematosus

366

204

30.00

307.65

4.0

1.5

0.19

0.23

g/l

5.82

353

192

Autoimmune diseases

3813

6029

3.35

307.65

2.2

1.2

0.22

0.24

g/l

20.98

3637

5711

Asthma (only as main-diagnosis)

2139

4538

2.93

307.65

1.6

1.7

0.24

0.23

g/l

2.40

2038

4311

Vasculitis limited to skin, not elsewhere classified

303

198

22.40

307.65

1.8

1.5

0.24

0.23

g/l

0.15

291

190

Other bacterial diseases

2764

7864

2.50

307.65

1.8

1.6

0.24

0.23

g/l

7.41

2604

7476

Inflammatory bowel disease treatment related agents

5026

6806

4.42

307.65

2.2

1.4

0.23

0.24

g/l

8.89

4781

6446

Asthma

2377

4538

2.89

307.65

1.6

1.7

0.24

0.23

g/l

3.26

2268

4311

Implicit Sepsis

2105

6334

2.67

307.65

1.9

1.6

0.24

0.23

g/l

1.71

1976

6018

Other specified/unspecified systemic involvement of connective tissue

865

438

31.29

307.65

3.4

1.2

0.20

0.25

g/l

20.85

839

412

Autoimmune diseases excluding thyroid diseases, strict definition

4231

5815

4.26

307.65

2.3

1.2

0.22

0.24

g/l

31.53

4038

5513

Reimbursement for rheumatic diseases

3144

6235

5.50

307.65

2.8

1.3

0.21

0.24

g/l

49.03

3019

5888

Anaemias

1007

1251

5.68

307.65

2.3

1.8

0.23

0.22

g/l

4.48

961

1196

Other arthritis (FG)

1274

2449

5.58

307.65

1.8

1.2

0.23

0.24

g/l

4.90

1220

2314

Polyarthropathies

2707

4795

3.95

307.65

1.9

1.6

0.23

0.24

g/l

1.73

2581

4539

General symptoms and signs

3583

6481

2.86

307.65

1.9

1.6

0.23

g/l

1.11

3403

6162

Acute renal failure

854

1482

6.28

307.65

1.9

1.5

0.25

0.23

g/l

6.69

808

1396

Dialysis, with operation codes

635

1015

7.00

307.65

1.9

1.5

0.25

0.24

g/l

4.50

598

958

Systemic sclerosis (FG)

270

134

28.61

307.65

2.3

1.1

0.20

0.24

g/l

3.98

258

124

Bacterial Sepsis

1371

3577

3.57

307.65

1.9

1.5

0.24

0.23

g/l

1.51

1275

3381

Diseases of the skin and subcutaneous tissue

2989

6012

2.56

307.65

1.9

1.6

0.23

g/l

0.67

2831

5726

Cardiovascular diseases

2047

3934

2.93

307.65

2.1

1.7

0.23

0.22

g/l

3.54

1967

3736

Rheumatoid arthritis

1182

2649

4.29

307.65

2.0

1.5

0.22

0.24

g/l

11.64

1122

2499

Other and unspecified dermatitis

1835

5795

3.33

307.65

1.9

1.7

0.23

g/l

3.03

1740

5503

Dermatitis

2059

7026

3.06

307.65

1.8

1.6

0.23

g/l

2.72

1951

6668

Other necrotizing vasculopathies (FG)

414

345

14.40

307.65

2.1

1.2

0.24

0.25

g/l

0.51

393

324

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

604

311

15.94

307.65

1.8

1.2

0.23

0.24

g/l

2.26

581

288

Other and unspecified effects of external causes

1134

3259

3.71

307.65

1.7

1.8

0.23

g/l

0.93

1037

3115

Other systemic involvement of connective tissue

2348

2371

11.94

307.65

2.6

1.2

0.21

0.24

g/l

51.26

2258

2221

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2637

6954

2.44

307.65

1.9

1.6

0.24

0.23

g/l

2.17

2502

6601

Second line medication for Crohn's disease

2646

6581

4.32

307.65

2.6

1.5

0.22

0.24

g/l

21.23

2535

6229

Glomerular diseases

1141

1650

7.94

307.65

3.0

1.5

0.25

0.24

g/l

4.60

1083

1561

Other disorders of skin and subcutaneous tissue

2169

7148

2.89

307.65

2.2

1.6

0.23

g/l

1.68

2042

6779

Other specific joint derangements/joint disorders

2619

5478

3.34

307.65

1.8

1.7

0.23

g/l

1.93

2478

5199

Certain disorders involving the immune mechanism

861

2034

4.61

307.65

1.9

1.7

0.24

g/l

0.19

804

1932

Autoimmune diseases related-to ILD

3776

8263

4.26

307.65

2.7

1.3

0.22

0.24

g/l

35.22

3612

7803

Systemic connective tissue disorders

3344

3076

13.37

307.65

3.1

1.2

0.21

0.24

g/l

65.63

3211

2882

Glomerulonephritis

587

884

7.59

307.65

2.7

1.5

0.25

0.23

g/l

3.56

556

833

Pain in joint

2249

4062

3.84

307.65

1.8

1.6

0.23

g/l

0.98

2134

3857

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3547

8383

3.17

307.65

2.0

1.6

0.23

g/l

3.29

3343

7968

Urticaria and erythema

1504

4483

3.57

307.65

1.9

1.8

0.23

g/l

0.47

1414

4263

ILD medications: immunosuppressive drugs

3276

5166

6.61

307.65

2.7

1.3

0.22

0.24

g/l

15.93

3129

4887

Nephropathy related operations

600

1069

6.26

307.65

2.0

1.4

0.26

0.24

g/l

3.07

564

1008

Other peripheral vascular diseases

593

680

10.45

307.65

1.9

1.7

0.21

0.23

g/l

9.48

577

638

Asthma, excluding more controls

2329

4287

2.99

307.65

1.6

1.7

0.24

0.23

g/l

3.24

2225

4070

Other systemic involvement of connective tissue (FG)

2307

1856

14.94

307.65

2.7

1.2

0.21

0.24

g/l

47.53

2218

1744

ILD medications: azathioprine

759

1042

8.05

307.65

4.0

1.3

0.20

0.24

g/l

15.13

732

993

Asthma (mode)

2333

4591

2.88

307.65

1.6

1.7

0.24

0.23

g/l

2.91

2227

4363

First line medication for Crohn's disease

4675

6106

4.39

307.65

2.2

1.3

0.23

0.24

g/l

6.86

4444

5791

Renal tubulo-interstitial diseases

2802

8025

2.78

307.65

1.9

1.7

0.25

0.23

g/l

18.96

2668

7600

Other joint disorders

2507

5624

2.43

307.25

1.8

1.7

0.23

g/l

1.54

2383

5337

Diseases of arteries, arterioles and capillaries

1822

5157

2.73

305.49

1.7

1.6

0.23

0.24

g/l

4.11

1741

4861

ILD, hospital admissions 1, main diag only

569

1030

6.09

304.51

1.9

1.4

0.23

0.24

g/l

2.33

548

973

Pain in limb

2247

6823

2.45

302.53

1.8

1.7

0.24

0.23

g/l

2.04

2136

6464

Neurological diseases, wide definition

905

964

4.86

301.42

1.8

1.2

0.23

g/l

0.70

862

909

Cardiovascular diseases (excluding rheumatic etc)

2063

4710

2.61

296.17

2.1

1.7

0.24

0.22

g/l

13.08

1979

4474

Asthma, unspecified (mode)

1477

4071

2.97

294.98

1.6

0.24

0.23

g/l

2.23

1411

3861

Diseases of the musculoskeletal system and connective tissue

1511

2452

3.17

293.11

2.0

1.2

0.23

0.24

g/l

6.00

1442

2334

Influenza and pneumonia

2983

9320

2.16

292.91

1.9

1.7

0.23

g/l

0.84

2827

8848

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

426

602

8.04

292.21

1.9

1.4

0.25

0.24

g/l

1.01

402

577

Examination and observation for other reasons

1765

3969

2.78

292.14

1.8

1.6

0.23

0.24

g/l

3.87

1672

3799

Coagulation defects, purpura and other haemorrhagic conditions

794

1993

4.30

285.28

2.5

1.7

0.22

0.23

g/l

6.62

741

1885

Pneumonias (Asthma/COPD co-morbidities)

2810

9202

2.17

283.20

1.9

1.6

0.24

0.23

g/l

1.62

2664

8736

Systemic sclerosis, icd10

270

231

16.52

279.28

2.3

1.7

0.20

0.24

g/l

5.99

258

222

Any reimbursement code in KELA

1735

3152

2.83

278.84

2.0

1.4

0.23

g/l

0.48

1658

2984

Certain infectious and parasitic diseases

2792

6399

2.23

278.70

1.9

1.6

0.23

g/l

0.21

2648

6108

Asthma-related infections

1743

6872

2.58

278.59

1.7

0.24

0.23

g/l

3.09

1657

6502

Asthma, hospital admission 2, infections

1743

6872

2.58

278.59

1.7

0.24

0.23

g/l

3.09

1657

6502

All pneumoniae

2815

9262

2.15

277.34

1.9

1.6

0.24

0.23

g/l

1.53

2669

8793

ILD, hospital admission 2, with pulmonary infections

415

601

7.64

276.77

1.9

1.4

0.23

0.24

g/l

0.95

395

565

Condition for Implicit Sepsis (Organ dysfunction codes)

2302

7403

2.32

275.33

1.8

1.6

0.24

0.23

g/l

2.12

2167

7035

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1738

6453

2.58

274.49

1.7

1.6

0.23

0.24

g/l

1.15

1649

6093

Other and unspecified urticaria

829

2208

4.03

274.03

1.9

1.8

0.23

g/l

1.13

773

2094

Pneumonia, organism unspecified

2503

8313

2.23

273.97

1.9

1.6

0.24

0.23

g/l

1.19

2376

7893

Infections, IBD-co-morbidities

491

535

7.00

273.32

2.0

1.2

0.23

0.24

g/l

1.57

460

500

Immunodeficiencies

357

453

9.55

272.10

2.1

1.6

0.22

0.24

g/l

2.08

320

427

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2726

9126

2.15

270.16

1.9

1.7

0.24

0.23

g/l

1.13

2581

8668

Hypertensive diseases (excluding secondary)

1629

3482

2.81

269.22

2.1

1.6

0.25

0.23

g/l

14.64

1555

3293

Care involving dialysis

420

640

7.45

268.87

2.0

1.4

0.26

0.24

g/l

2.31

399

602

Tramadol

2206

6156

2.36

267.59

1.7

0.24

0.23

g/l

4.37

2092

5832

Septicaemia

1115

3476

3.21

265.08

1.9

1.5

0.24

0.23

g/l

3.03

1050

3288

Unspecified kidney failure

400

594

7.39

260.25

1.6

1.4

0.26

0.23

g/l

5.90

382

560

GASTRO-related operations

2274

4978

2.34

253.24

1.9

1.6

0.23

g/l

1.64

2159

4779

Any gastric operation

2274

4978

2.34

253.24

1.9

1.6

0.23

g/l

1.64

2159

4779

Symptoms and signs involving the circulatory and respiratory systems

2819

6756

2.14

253.05

1.9

1.7

0.23

g/l

1.02

2682

6424

Heart failure and antihypertensive medication

768

1215

4.37

252.85

1.8

1.6

0.24

0.23

g/l

2.28

734

1149

Other heart diseases

1460

3534

2.82

252.53

2.0

1.7

0.24

0.22

g/l

7.15

1385

3354

Malaise and fatigue

1276

3748

2.93

252.11

1.7

1.6

0.23

g/l

0.41

1194

3543

Other pulmonary diagnosis

2148

4594

2.39

250.65

1.8

1.7

0.24

0.23

g/l

1.69

2045

4366

Aplastic and other anaemias

1221

4076

2.95

250.29

1.9

1.5

0.23

0.24

g/l

0.22

1143

3845

Explicit Sepsis

1186

3967

2.98

247.73

1.9

1.5

0.24

0.23

g/l

1.94

1119

3754

Excluding asthma or asthma-COPD overlap

2137

4594

2.38

246.60

1.8

1.7

0.24

0.23

g/l

1.85

2037

4366

Other septicaemia

992

3089

3.28

245.84

1.8

1.5

0.24

0.23

g/l

2.35

938

2914

1365

5167

2.72

242.35

1.7

1.8

0.24

0.23

g/l

2.56

1305

4889

Antihypertensive medication - note that there are other indications

1848

4156

2.50

240.84

2.2

1.7

0.23

0.22

g/l

7.17

1767

3950

ILD differential diagnosis

2116

4591

2.36

239.26

1.8

1.7

0.24

0.23

g/l

1.68

2017

4363

Abnormal findings on diagnostic imaging of lung

1257

4502

2.82

238.69

1.7

1.5

0.23

0.24

g/l

1.10

1187

4239

COPD differential diagnosis

2115

4593

2.36

238.69

1.8

1.7

0.24

0.23

g/l

1.69

2016

4365

Asthma (diagnoses ohter than nonallergic)

2388

9880

2.12

237.15

1.6

1.7

0.24

0.23

g/l

3.99

2272

9356

Other and unspecified anaemias

1109

3737

2.98

232.95

1.8

1.6

0.23

0.24

g/l

0.26

1042

3516

Other anaemias

1115

3776

2.96

230.81

1.9

1.5

0.23

0.24

g/l

0.27

1048

3553

Abnormal findings on examination of blood, without diagnosis

1255

4402

2.77

227.85

1.8

1.6

0.24

g/l

0.07

1184

4171

Other diseases of pleura

1168

3726

2.88

226.08

1.9

1.5

0.24

g/l

0.27

1108

3507

Opioids

2687

6991

2.06

222.76

1.8

1.7

0.24

0.23

g/l

6.25

2540

6631

COPD/asthma related infections

2782

6964

2.04

222.37

1.9

1.6

0.24

0.23

g/l

1.95

2647

6611

COPD/asthma/ILD related infections

2782

6964

2.04

222.37

1.9

1.6

0.24

0.23

g/l

1.95

2647

6611

Fibromyalgia

437

832

5.81

221.89

2.0

1.8

0.24

0.23

g/l

0.60

414

777

Hypothyroidism, strict autoimmune

1707

4766

2.42

221.76

1.8

1.2

0.23

0.24

g/l

6.91

1605

4511

Purpura and other haemorrhagic conditions

548

1263

4.71

220.79

2.5

1.6

0.22

0.24

g/l

4.66

505

1196

Pain in throat and chest

2209

6343

2.18

218.89

1.8

1.6

0.23

g/l

0.31

2107

6023

Codeine

2537

6875

2.07

215.86

1.8

1.7

0.24

0.23

g/l

5.53

2395

6521

Viral Sepsis

629

1640

4.06

213.16

2.3

1.5

0.24

0.23

g/l

0.10

579

1553

Other disorders of lacrimal gland

1060

3809

2.91

212.91

2.4

1.6

0.22

0.24

g/l

5.57

1014

3584

Implicit viral Sepsis

627

1637

4.06

212.08

2.3

1.5

0.24

0.23

g/l

0.11

578

1550

Nephrotic syndrome

247

271

11.31

211.84

2.3

1.3

0.26

0.24

g/l

2.20

236

256

Extracorporeal dialysis

326

491

7.62

211.69

2.1

1.4

0.25

0.24

g/l

1.08

306

471

ILD, hospital admissions 3, with pneumonia sepsis

339

527

7.09

211.60

1.9

1.4

0.23

0.24

g/l

0.56

324

498

Secondary hypertension

336

509

7.12

211.55

2.9

1.6

0.25

0.23

g/l

4.19

316

481

Ulcer of lower limb, not elsewhere classified

470

987

5.11

211.46

1.8

1.4

0.25

0.24

g/l

1.03

440

932

Hypertensive diseases

2122

5639

2.18

206.71

2.0

1.7

0.25

0.23

g/l

17.48

2016

5365

Medical observation and evaluation for suspected diseases and conditions

1800

3985

2.36

206.14

1.9

1.6

0.23

0.24

g/l

2.40

1726

3813

Heart failure,strict

1231

3359

2.73

205.66

1.7

1.5

0.24

g/l

0.43

1175

3165

Hypertension

2115

5633

2.17

204.76

2.0

1.7

0.25

0.23

g/l

17.59

2009

5359

Hypertension, essential

2038

5399

2.20

204.59

1.8

1.7

0.25

0.23

g/l

20.11

1927

5136

Asthma-related pneumonia

992

3520

2.92

202.48

1.7

0.24

0.23

g/l

1.62

943

3300

Other heart diseases, wide

2492

7849

2.01

202.27

1.9

1.7

0.24

0.23

g/l

1.46

2372

7451

Soft tissue disorders

2716

7265

1.98

201.95

1.8

1.7

0.23

g/l

1.24

2587

6889

Asthma-related pneumonia or sepsis

993

3531

2.92

201.86

1.7

0.24

0.23

g/l

1.58

944

3310

Asthma, hospital admissions 3, pneumonia

993

3531

2.92

201.86

1.7

0.24

0.23

g/l

1.58

944

3310

Polymyalgia rheumatica

423

845

5.36

201.64

1.6

1.2

0.24

0.25

g/l

1.22

400

789

L04AD Calcineurin inhibitors

484

1096

4.85

200.34

2.8

1.5

0.23

0.24

g/l

0.05

455

1036

Asthma, hospital admissions , main diagnosis only

2219

9988

2.04

200.23

1.6

1.8

0.24

0.23

g/l

2.14

2113

9456

Sulfasalazine

768

2387

3.34

197.83

1.5

1.4

0.22

0.24

g/l

6.98

719

2261

Chronic lower respiratory diseases

3139

9293

1.86

196.83

1.7

0.24

0.23

g/l

3.16

2985

8812

Pain, not elsewhere classified

774

2439

3.30

195.21

1.8

1.7

0.24

0.23

g/l

0.76

744

2313

Parasetamol

2102

5081

2.15

194.08

1.8

1.7

0.24

0.23

g/l

5.35

2001

4823

2898

8226

1.89

190.94

1.9

1.7

0.24

0.23

g/l

1.76

2750

7806

Asthma, including avohilmo

3021

9637

1.86

190.94

1.6

1.8

0.24

0.23

g/l

2.64

2876

9131

Enlarged lymph nodes

520

1281

4.29

190.36

2.6

1.7

0.22

0.23

g/l

1.81

501

1207

Gout

656

1704

3.65

189.05

1.4

0.26

0.24

g/l

6.56

621

1610

Diseases of arteries, arterioles and capillaries (FINNGEN)

663

1262

3.82

188.04

1.6

1.5

0.24

0.23

g/l

1.26

628

1186

Other disorders involving the immune mechanism, not elsewhere classified

232

279

10.19

185.13

2.0

1.5

0.26

0.24

g/l

1.57

217

266

Other diseases of pericardium

227

262

9.87

184.51

2.6

1.4

0.23

0.24

g/l

0.29

213

245

Disorders of thyroid, IBD co-morbidities

449

670

5.05

183.57

1.8

1.2

0.23

0.24

g/l

1.48

421

627

Disorders of lacrimal system

1183

4830

2.54

183.21

2.3

1.6

0.22

0.23

g/l

5.51

1133

4558

Methotrexate

467

1096

4.50

182.29

2.3

1.3

0.21

0.24

g/l

9.65

449

1039

Cerebrovascular diseases (FINNGEN)

851

2005

3.14

181.95

2.0

1.6

0.24

0.23

g/l

4.20

814

1891

Seropositive rheumatoid arthritis, wide

841

2910

3.03

181.34

2.0

1.6

0.21

0.24

g/l

14.26

800

2736

Dorsalgia

2578

7367

1.93

180.79

1.8

1.7

0.23

g/l

0.11

2440

7003

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

929

1511

3.15

179.46

1.8

1.5

0.23

g/l

0.65

877

1451

Pleural effusion

468

1136

4.37

175.06

2.0

1.4

0.24

g/l

0.03

449

1077

Other/unspecified seropositive rheumatoid arthritis

824

2880

3.00

174.45

2.0

1.6

0.21

0.24

g/l

13.59

784

2712

Immunodeficiency with predominantly antibody defects

218

263

10.43

174.38

2.1

1.7

0.22

0.24

g/l

1.05

202

249

Codeine or tramadol medication

2897

8929

1.83

173.41

1.8

1.7

0.24

0.23

g/l

5.08

2736

8473

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

815

2843

3.01

173.23

1.9

1.6

0.21

0.24

g/l

13.10

775

2676

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

216

263

10.07

170.73

1.9

1.5

0.27

0.24

g/l

2.32

201

251

Bronchitis

2682

9720

1.84

170.68

1.9

1.7

0.24

0.23

g/l

1.26

2542

9221

Symptoms and signs involving the skin and subcutaneous tissue

1788

8857

2.06

169.38

1.9

1.7

0.23

g/l

3.16

1704

8384

Diseases of oesophagus, stomach and duodenum

2661

8896

1.85

168.80

1.8

1.7

0.23

g/l

0.29

2500

8464

Polyneuropathies and other disorders of the peripheral nervous system

641

1978

3.41

168.39

1.8

1.5

0.23

0.24

g/l

2.70

607

1871

Erysipelas

1243

4873

2.39

167.47

1.7

1.5

0.24

0.23

g/l

2.98

1162

4624

Heart failure, strict

1287

3955

2.41

167.15

1.7

1.5

0.24

g/l

0.00

1226

3720

Other and unspecified polyneuropathies, also in other diseases

573

1671

3.62

164.83

1.8

1.5

0.23

0.24

g/l

2.53

546

1586

Migraine

1413

5504

2.25

162.05

1.9

0.22

0.23

g/l

0.81

1340

5232

CR(E)ST syndrome

161

144

15.59

161.73

2.0

1.7

0.20

0.24

g/l

4.66

151

139

Neurological diseases

2266

5961

1.95

160.34

1.7

0.23

g/l

1.60

2155

5659

Episodal and paroxysmal disorders

2817

8109

1.81

160.26

1.8

1.7

0.23

g/l

1.72

2683

7696

All-cause Heart Failure

1253

3888

2.38

159.70

1.7

1.5

0.24

g/l

0.08

1196

3656

Hypothyroidism (congenital or acquired)

745

1349

3.26

158.86

2.1

1.8

0.23

0.22

g/l

2.75

701

1285

Hypothyroidism and >3 levothyroxin purchases

732

1338

3.24

154.16

2.0

1.8

0.23

0.22

g/l

2.92

690

1275

Hypothyroidism, levothyroxine purchases

732

1338

3.24

154.16

2.0

1.8

0.23

0.22

g/l

2.92

690

1275

Gout, FINNGEN

656

2160

3.15

153.49

1.4

0.26

0.24

g/l

7.61

621

2028

Acute upper respiratory infections

2574

9066

1.81

153.31

1.8

1.7

0.24

0.23

g/l

1.59

2447

8594

Low back pain

1818

7140

2.00

152.92

1.8

1.7

0.24

0.23

g/l

0.79

1714

6787

Polyarthrosis

538

1507

3.58

151.93

1.7

1.5

0.23

0.24

g/l

2.83

516

1420

Chronic nephritic syndrome

223

322

7.97

150.68

3.0

1.4

0.25

0.24

g/l

0.14

213

307

Seronegative rheumatoid arthritis

354

779

4.81

150.02

1.8

1.2

0.22

0.24

g/l

5.70

334

731

Cough

1033

4149

2.46

149.53

1.8

1.6

0.23

g/l

0.26

981

3933

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1181

3212

2.39

146.93

2.0

1.7

0.23

g/l

1.91

1129

3038

Other dorsopathies, not elsewhere classified

2514

7412

1.82

146.57

1.7

0.23

g/l

0.12

2375

7046

Persons encountering health services for specific procedures and health care

2663

9487

1.77

146.53

1.8

1.7

0.24

0.23

g/l

2.02

2519

9009

Metabolic disorders

2260

7692

1.86

146.24

1.6

1.7

0.25

0.23

g/l

12.06

2128

7307

Pain (limb, back, neck, head abdominally)

1729

4239

2.08

146.02

1.7

1.6

0.23

g/l

0.11

1637

4025

Osteopathies and chondropathies

1371

6190

2.16

145.47

2.0

1.6

0.23

g/l

0.31

1310

5855

Dental caries

737

2650

2.86

144.53

2.0

1.6

0.23

g/l

0.17

702

2512

Other diseases of intestines

2648

8870

1.76

142.66

1.7

0.23

g/l

0.35

2521

8421

Other (seronegative) rheumatoid arthritis, wide

595

1950

3.21

141.57

1.9

1.6

0.22

0.24

g/l

6.81

559

1831

Acute upper respiratory infections of multiple and unspecified sites

1881

7456

1.93

141.34

1.9

1.7

0.24

0.23

g/l

2.82

1785

7076

General examination and investigation of persons without complaint and reported diagnosis

1560

3984

2.12

141.26

1.8

1.6

0.23

0.24

g/l

5.99

1489

3812

Disorders of eyelid, lacrimal system and orbit

2035

8699

1.87

140.82

2.0

1.6

0.23

g/l

3.30

1934

8241

Myalgia

663

2339

2.95

137.69

1.7

0.23

g/l

0.01

629

2220

Persons encountering health services in other circumstances, wide

2900

8930

1.71

136.94

1.8

1.7

0.23

g/l

0.80

2767

8450

Lower back pain or/and sciatica

2475

9928

1.76

136.92

1.7

0.24

0.23

g/l

1.81

2333

9425

Giant cell arteritis

185

241

8.68

136.23

1.7

1.1

0.25

0.24

g/l

0.56

172

224

Dentinal caries

651

2281

2.95

135.42

2.0

1.5

0.24

0.23

g/l

0.21

621

2158

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2669

8914

1.73

135.13

1.8

1.7

0.23

g/l

0.25

2549

8435

Other immunodeficiencies

130

113

16.60

133.56

2.7

1.5

0.20

0.23

g/l

2.14

113

Obesity related asthma

879

3631

2.51

132.82

1.5

1.7

0.26

0.23

g/l

12.79

839

3420

Other special examinations and investigations of persons without complaint or reported diagnosis

1596

3985

2.06

132.47

1.9

1.6

0.23

0.24

g/l

1.88

1514

3813

Intestinal infectious diseases

2255

10057

1.78

131.64

1.8

1.7

0.23

g/l

0.21

2115

9558

Complications of surgical and medical care, not elsewhere classified

2317

9557

1.77

131.57

1.8

1.7

0.24

0.23

g/l

1.11

2179

9075

Symptoms and signs involving the nervous and musculoskeletal systems

1420

7130

2.04

131.43

1.8

1.7

0.23

g/l

0.50

1353

6743

Diseases of the respiratory system

1542

3771

2.08

131.32

1.8

1.7

0.23

g/l

0.50

1459

3591

Other abnormal immunological findings in serum

161

191

10.58

130.51

1.9

1.5

0.21

0.23

g/l

2.70

151

183

Diarrhoea and gastroenteritis of presumed infectious origin

1727

8392

1.91

130.19

1.8

1.7

0.23

g/l

0.55

1629

7975

Cardiac arrhythmias

1589

5348

2.01

130.11

1.8

1.7

0.24

0.23

g/l

5.00

1511

5063

Nerve, nerve root and plexus disorders

2489

9162

1.73

128.75

1.6

1.7

0.24

0.23

g/l

0.79

2361

8676

Depression medications

782

1412

2.85

128.35

1.7

1.8

0.24

0.22

g/l

5.68

747

1346

Atrial fibrillation and flutter

731

1738

2.82

127.40

1.7

1.5

0.24

0.23

g/l

3.06

694

1643

Dorsopathies

2515

7480

1.74

126.23

1.7

0.23

g/l

0.15

2375

7111

Undetermined asthma, excluding more controls

362

924

4.10

125.98

1.7

1.5

0.24

0.23

g/l

0.18

351

871

Complications of medical and surgical care

1723

8871

1.88

125.42

1.8

1.7

0.24

0.23

g/l

2.08

1610

8418

Spondylopathies

1820

5930

1.90

125.17

1.6

1.7

0.24

g/l

0.33

1724

5617

Rheumatism, unspecified

454

1362

3.52

125.12

1.9

1.6

0.24

0.23

g/l

0.83

433

1279

Isolated proteinuria

188

279

7.98

124.81

3.1

1.4

0.24

g/l

0.20

183

267

Acute sinusitis

1335

6210

2.05

124.28

1.9

1.7

0.23

g/l

0.86

1267

5893

Diseases of salivary glands

569

1965

3.02

123.12

2.4

1.6

0.21

0.24

g/l

7.22

542

1858

Other and unspecified iron deficiency

816

3376

2.50

122.68

1.9

1.6

0.23

g/l

0.05

782

3183

Diabetic nephropathy, excluding more controls

428

1016

3.72

121.98

1.7

1.5

0.27

0.25

g/l

4.10

406

973

Asthma/COPD (KELA code 203)

2254

9258

1.74

121.64

1.6

1.7

0.24

0.23

g/l

2.74

2142

8777

Nutritional anaemias

1125

5187

2.16

121.32

1.8

1.6

0.23

g/l

0.16

1073

4891

Undetermined asthma

362

952

3.98

120.84

1.7

1.5

0.24

0.23

g/l

0.17

351

900

IgA nephropathy (IgA glomerulonephritis)

163

215

9.11

120.33

1.6

1.5

0.27

0.24

g/l

3.17

151

206

Anxiety disorders, excluding more controls

2055

7745

1.79

119.73

1.9

1.7

0.23

g/l

0.25

1942

7367

Other disorders of skin and subcutaneous tissue, not elsewhere classified

416

1215

3.60

119.39

1.9

1.5

0.23

0.24

g/l

0.58

389

1145

Other acute lower respiratory infections

1269

6041

2.05

118.63

1.8

1.7

0.24

0.23

g/l

0.83

1206

5726

Haemorrhage from respiratory passages

734

2701

2.59

118.43

1.7

1.5

0.24

g/l

0.10

685

2548

Pericarditis

170

236

8.06

118.31

3.0

1.4

0.23

0.24

g/l

0.81

160

223

Other diseases of blood and blood-forming organs, wide

625

2321

2.81

118.24

2.2

1.6

0.22

0.24

g/l

5.75

580

2198

Allergic asthma (mode), excluding more controls

619

2230

2.80

118.18

1.5

1.8

0.24

0.23

g/l

2.38

582

2131

Neurotic, stress-related and somatoform disorders

2194

9113

1.74

117.81

1.9

1.7

0.23

g/l

0.82

2070

8659

Defects in the complement system

103

22.05

117.35

2.4

1.4

0.19

0.24

g/l

3.52

Anxiety disorders

2209

9174

1.74

117.31

1.9

1.7

0.23

g/l

0.80

2084

8717

Transplanted organ and tissue status

341

887

4.12

116.83

1.8

1.5

0.26

0.24

g/l

2.34

320

841

Gastrointestinal diseases

1528

3900

2.00

116.16

1.9

1.7

0.23

g/l

0.36

1445

3727

Iron deficiency anaemia

979

4438

2.24

115.88

1.9

1.6

0.23

g/l

0.01

938

4181

Acute tubulo-interstitial nephritis

1367

6233

1.98

115.61

1.8

1.7

0.24

0.23

g/l

4.81

1289

5892

Chronic ulcer of skin, not elsewhere classified

234

456

5.54

115.25

2.0

1.3

0.24

g/l

0.04

218

433

Infections of the skin and subcutaneous tissue

1385

7194

1.96

114.70

2.0

1.7

0.24

0.23

g/l

1.27

1311

6847

Other headache syndromes

1081

5173

2.14

114.39

1.8

1.7

0.23

g/l

0.17

1026

4903

Viral infections characterized by skin and mucous membrane lesions

1038

4899

2.18

113.80

2.3

1.6

0.23

g/l

2.01

980

4647

Gout, idiopatic and unspecified

555

1974

2.92

113.48

1.4

0.26

0.24

g/l

7.46

529

1865

Allergic asthma (mode)

619

2280

2.74

113.26

1.5

1.8

0.24

0.23

g/l

2.33

582

2180

Temporal arteritis

162

225

8.12

112.92

1.8

1.1

0.25

0.24

g/l

0.34

150

209

Abnormal findings on examination of urine, without diagnosis

211

392

6.02

110.68

2.9

1.4

0.24

g/l

0.03

204

371

Chronic sinusitis

1075

5197

2.12

110.56

1.7

0.24

0.23

g/l

0.35

1019

4937

Vocal cord dysfunction

320

750

4.10

110.42

1.7

1.2

0.23

0.24

g/l

2.13

297

709

Pulmonary heart disease, diseases of pulmonary circulation

730

3028

2.49

109.09

1.8

1.6

0.25

0.23

g/l

2.87

689

2848

STROKE

1287

4519

2.02

108.53

1.8

1.6

0.24

0.23

g/l

1.86

1219

4282

Non-ischemic cardiomyopathy

654

2080

2.66

108.07

1.8

1.5

0.23

0.24

g/l

0.22

619

1944

Hypothyroidism, drug reimbursement

410

846

3.58

107.99

1.8

1.7

0.23

0.22

g/l

0.75

386

809

Venous thromboembolism

1179

5768

2.03

107.52

1.9

1.6

0.24

0.23

g/l

2.65

1116

5427

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

265

608

4.68

107.36

2.0

1.5

0.22

0.23

g/l

0.70

247

571

Bacterial pneumoniae

904

3625

2.26

107.26

1.9

1.5

0.24

0.23

g/l

0.24

838

3431

Migraine with aura

701

2885

2.52

107.00

1.9

0.22

0.23

g/l

1.28

664

2757

Secondary right heart disease

177

290

6.78

105.46

1.8

1.4

0.24

g/l

0.09

169

276

Gastro-oesophageal reflux disease

1533

7478

1.85

104.98

1.8

1.6

0.23

0.24

g/l

2.24

1440

7104

Diseases of the eye and adnexa

2030

5870

1.76

104.88

1.9

1.7

0.23

g/l

0.58

1938

5590

Atrial fibrillation and flutter with reimbursement

562

1263

2.93

104.48

1.6

1.5

0.24

0.23

g/l

1.65

535

1187

Asthma and allergy

379

1117

3.48

104.37

1.6

1.7

0.24

0.22

g/l

3.64

357

1070

Other general symptoms and signs

201

369

5.85

104.26

1.7

0.22

g/l

0.08

188

352

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

192

348

6.10

103.07

2.1

1.6

0.21

0.23

g/l

1.08

183

328

Complications of procedures, not elsewhere classified

1825

9179

1.75

102.94

1.8

1.7

0.24

0.23

g/l

0.81

1720

8712

Temporomandibular joint disorders

430

1400

3.19

102.90

1.9

1.7

0.22

0.23

g/l

0.78

412

1330

Biological medication for rheuma

503

1799

2.94

102.62

1.6

1.8

0.22

0.23

g/l

1.65

471

1701

Acute bronchitis

958

4472

2.15

102.13

1.8

1.6

0.24

0.23

g/l

1.27

908

4230

Gonarthrosis [arthrosis of knee](FG)

1312

3966

1.97

101.51

1.6

1.2

0.24

0.25

g/l

1.09

1241

3744

Bacterial pneumonia, not elsewhere classified

850

3403

2.26

101.20

1.9

1.5

0.24

0.23

g/l

0.37

789

3219

Other and unspecified coagulation defects

223

472

5.23

100.77

3.5

1.7

0.21

0.24

g/l

2.99

214

448

Idiopathic urticaria

141

193

8.71

100.74

1.6

0.23

g/l

0.02

133

185

Disturbances of skin sensation

752

3281

2.37

100.73

1.9

1.8

0.23

g/l

1.23

713

3123

Non-allergic asthma (mode), excluding more controls

445

1486

3.06

99.72

1.8

1.5

0.23

g/l

0.29

422

1400

Osteoporosis

589

2190

2.65

99.72

2.3

1.5

0.22

0.24

g/l

3.16

559

2041

Gout, unspecified

460

1589

3.01

99.42

1.3

1.4

0.26

0.24

g/l

8.11

436

1501

Asthma and allergy, excluding more controls

379

1152

3.38

99.39

1.6

1.7

0.24

0.22

g/l

3.28

357

1100

Idiopathic pulmonary fibrosis

223

475

5.02

98.86

1.8

1.4

0.22

0.24

g/l

2.80

213

449

Diabetic nephropathy

429

1414

3.15

98.85

1.7

1.4

0.27

0.25

g/l

3.97

407

1337

Other symptoms and signs involving the nervous and musculoskeletal systems

1025

5095

2.06

98.03

1.8

1.7

0.23

g/l

0.75

982

4830

Hypertensive heart and/or renal disease

513

1417

2.88

97.84

1.6

1.5

0.25

0.23

g/l

5.97

484

1342

Endocrine, nutritional and metabolic diseases

1971

5864

1.73

97.83

1.7

1.8

0.24

0.22

g/l

17.86

1877

5572

Symptoms and signs involving the digestive system and abdomen

2304

7035

1.66

97.75

1.8

1.7

0.23

g/l

0.58

2174

6702

Depression

2245

9530

1.65

97.74

1.7

0.23

g/l

0.38

2124

9056

Mood disorders, excluding more controls

2200

8159

1.66

97.72

1.8

1.7

0.23

g/l

0.44

2080

7752

Diseases of pulp and periapical tissues

836

3855

2.23

97.41

1.9

1.6

0.24

g/l

0.05

795

3657

Oxycodone

737

3111

2.35

97.27

1.7

1.5

0.24

0.23

g/l

2.48

690

2935

Other disorders of fluid, electrolyte and acid-base balance

663

2669

2.46

97.01

1.7

1.6

0.23

g/l

0.31

620

2522

Chronic rhinitis, nasopharyngitis and pharyngitis

811

3705

2.25

96.96

1.8

0.24

0.23

g/l

0.55

764

3525

Bacterial pneumonia (organism specified)

967

4272

2.11

96.89

1.9

1.6

0.24

0.23

g/l

0.19

897

4037

Other pleural conditions

275

699

4.15

96.77

1.9

1.4

0.24

g/l

0.13

265

660

Kidney transplant status

216

460

5.16

96.69

2.0

1.4

0.25

0.24

g/l

1.92

202

436

Exposure to unspecified factor

2204

10580

1.64

96.67

1.7

0.24

0.23

g/l

4.00

2085

10041

Allergic purpura

168

287

6.66

96.63

1.7

1.5

0.24

g/l

0.32

156

276

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

307

848

3.87

96.57

1.6

1.7

0.25

0.23

g/l

2.12

289

806

Gout, strict definition

406

1329

3.18

96.56

1.4

0.27

0.24

g/l

7.92

382

1255

Genitourinary diseases

1358

3553

1.95

96.47

1.8

1.5

0.24

0.23

g/l

2.63

1302

3370

Noninfective enteritis and colitis

1120

5783

1.98

95.58

1.7

0.23

g/l

0.30

1060

5500

Heart failure and bmi 25plus

720

2097

2.43

95.10

1.6

1.4

0.24

0.25

g/l

0.35

688

1971

Other pulmonary heart/vessel disease

181

335

5.93

94.88

1.7

1.5

0.24

0.23

g/l

0.30

173

319

Other and unspecified immunodeficiencies with predominantly antibody defects

114

132

11.30

94.87

1.8

1.6

0.23

g/l

0.25

102

127

Other/unspecified dorsalgia

877

4140

2.16

94.79

1.7

0.24

0.23

g/l

0.56

830

3929

Abdominal and pelvic pain

2281

7033

1.65

94.46

1.8

1.7

0.23

g/l

0.61

2145

6700

Sciatica+with lumbago

1148

5692

1.95

94.03

1.6

1.7

0.24

0.23

g/l

0.54

1084

5399

Mood [affective] disorders

2363

9789

1.61

93.45

1.8

1.7

0.23

g/l

0.54

2233

9303

Non-allergic asthma (mode)

445

1544

2.94

93.15

1.8

1.5

0.23

g/l

0.33

422

1456

Mood disorders

2365

9803

1.61

92.73

1.8

1.7

0.23

g/l

0.53

2235

9316

Codes for special purposes

1091

5650

1.98

92.72

1.9

1.8

0.24

0.23

g/l

1.37

1049

5374

Giant cell arteritis with polymyalgia rheumatica

162

278

6.54

92.47

1.8

1.5

0.25

0.23

g/l

0.97

150

262

Sleep disorders (combined)

2229

9108

1.63

91.94

1.6

1.7

0.25

0.23

g/l

13.36

2122

8625

Other intervertebral disc disorders

1831

6615

1.72

91.89

1.6

1.7

0.23

g/l

0.11

1729

6275

Spondylosis

1124

5015

1.96

91.43

1.6

0.24

g/l

0.29

1064

4745

Diseases of liver

789

3658

2.22

90.94

1.8

1.6

0.23

0.24

g/l

2.42

740

3475

Syncope and collapse

836

3471

2.17

90.92

1.7

1.6

0.23

g/l

0.04

797

3281

Provisional assignment of new diseases of uncertain etiology

1085

5646

1.97

90.91

1.9

1.8

0.24

0.23

g/l

1.42

1044

5369

Dermatographic urticaria

260

670

4.19

90.67

1.7

1.8

0.23

g/l

0.00

240

628

DVT of lower extremities and pulmonary embolism

880

4246

2.12

90.29

1.8

1.6

0.25

0.23

g/l

3.12

828

3997

Other and unspecified drugs and medicaments

282

776

3.88

89.29

1.6

1.7

0.25

0.24

g/l

1.23

264

735

Other coagulation defects

265

700

4.07

89.16

3.2

1.8

0.21

0.23

g/l

3.07

255

662

Thrombocytopenia, unspecified

235

568

4.44

89.15

2.7

1.5

0.20

0.24

g/l

7.44

212

543

Atopic dermatitis

1308

6206

1.83

86.38

1.9

1.7

0.23

g/l

1.07

1235

5913

Symptoms and signs involving cognition, perception, emotional state and behaviour

2138

9422

1.61

86.23

1.7

0.23

g/l

0.13

2012

8950

Spondylopathies (FG)

337

1056

3.31

86.11

1.7

1.2

0.23

0.24

g/l

0.76

318

992

Seropositive rheumatoid arthritis, strict definition

431

1561

2.89

85.86

1.6

0.22

0.24

g/l

5.30

408

1469

Bleeding

1695

7332

1.71

85.79

1.7

1.6

0.24

0.23

g/l

0.99

1587

6963

Disorders of lipoprotein metabolism and other lipidaemias

1655

6106

1.73

85.31

1.5

1.6

0.25

0.23

g/l

17.12

1563

5795

Covid-19 confirmed case

689

3105

2.29

85.30

1.9

1.7

0.24

0.23

g/l

1.52

662

2940

Care involving use of rehabilitation procedures

1416

7720

1.77

85.26

1.9

1.7

0.23

g/l

0.05

1321

7314

Other diseases of urinary system

2324

8335

1.59

84.64

1.8

1.7

0.23

g/l

0.08

2189

7930

Valvular heart disease excluding rheumatic fever

939

3405

2.06

84.62

1.8

1.5

0.22

0.24

g/l

3.99

880

3200

Non-rheumatic valve diseases

932

3368

2.06

84.53

1.8

1.5

0.22

0.24

g/l

4.35

874

3166

Hypothyroidism, other/unspecified

2031

8353

1.63

84.20

1.8

1.7

0.23

g/l

0.55

1904

7925

Disorders of conjunctiva

1882

9740

1.64

84.15

1.9

1.7

0.23

g/l

0.22

1788

9244

Pulmonary embolism

631

2754

2.36

84.13

1.8

1.6

0.25

0.23

g/l

3.36

595

2589

Chronic periapical parodontitis

511

2031

2.60

84.09

2.0

1.5

0.24

g/l

0.15

490

1912

Arthrosis

1406

4303

1.82

84.01

1.7

1.6

0.24

g/l

0.10

1333

4067

Disorders of the thyroid gland

2134

8795

1.61

83.95

1.8

1.7

0.23

g/l

0.23

2011

8341

Diseases of the digestive system

964

4937

1.99

83.91

1.8

1.6

0.23

g/l

2.19

905

4675

Hypothyreosis and Thyroxine purchase for inclusion criteria

2097

8705

1.61

83.61

1.8

1.7

0.23

g/l

0.72

1966

8263

Acquired haemolytic anaemia

129

196

7.60

83.44

3.7

1.4

0.19

0.24

g/l

7.67

115

187

Shoulder lesions

1603

5745

1.73

82.96

1.7

1.6

0.24

g/l

0.21

1519

5432

Abnormalities of heart beat

750

3499

2.17

82.66

2.0

1.6

0.23

g/l

0.19

716

3310

Disorders of skin appendages

1135

6182

1.87

82.49

2.0

1.7

0.23

g/l

0.74

1062

5898

Psoriatic and enteropathic arthropathies

284

823

3.59

82.32

1.7

1.2

0.24

g/l

0.49

273

777

Pulmonary heart disease

631

2781

2.33

82.24

1.8

1.6

0.25

0.23

g/l

3.37

595

2612

Irritable bowel syndrome

703

3247

2.23

81.93

1.7

0.23

g/l

0.24

673

3072

All anxiety disorders

1479

6949

1.74

81.87

1.8

0.23

g/l

0.47

1406

6611

Anxiety (asthma-related co-morbidities)

1451

6640

1.75

81.67

1.8

0.23

g/l

0.05

1379

6313

Symptoms and signs concerning food and fluid intake

260

717

3.79

81.17

1.9

1.5

0.23

g/l

0.51

246

672

Visual disturbances and blindness

1119

6105

1.87

80.99

1.9

1.7

0.23

g/l

0.32

1063

5778

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2073

8528

1.60

80.83

1.8

1.6

0.23

0.24

g/l

0.77

1969

8077

Explicit bacterial Sepsis

266

749

3.72

80.71

2.3

1.5

0.24

0.23

g/l

0.48

250

708

Other arrhythmias

1366

5977

1.78

80.58

1.8

1.6

0.23

g/l

0.92

1301

5665

Zoster [herpes zoster]

429

1599

2.79

80.56

2.6

1.5

0.22

0.24

g/l

2.60

403

1497

Symptoms and signs involving the urinary system

1592

7349

1.70

80.28

1.7

1.6

0.24

0.23

g/l

0.73

1493

6984

Visual disturbances

1060

5705

1.90

80.21

1.9

1.7

0.23

g/l

0.30

1006

5394

Conjunctivitis

1729

9252

1.65

79.98

1.9

1.7

0.23

g/l

0.25

1645

8779

All influenza

557

2356

2.43

79.81

1.9

1.6

0.23

g/l

0.55

523

2230

Rosacea

351

1186

3.12

79.69

2.3

1.7

0.22

0.23

g/l

1.74

332

1117

Migraine with aura and triptan purchases

472

1871

2.63

78.64

1.9

2.0

0.22

0.23

g/l

0.36

449

1775

Continuous positive airway pressure

419

1321

2.81

78.56

1.7

1.5

0.25

0.23

g/l

3.12

385

1254

Persons encountering health services for examination and investigation

1408

3985

1.79

78.50

1.8

1.6

0.23

0.24

g/l

0.54

1329

3813

Other/unspecified rheumatoid arthritis

341

1141

3.13

78.46

2.0

1.5

0.21

0.24

g/l

9.63

317

1080

Nausea and vomiting

609

2652

2.32

78.22

1.8

1.6

0.24

0.23

g/l

1.08

570

2528

Other disorders of urethra and urinary system

1555

6964

1.70

77.83

1.8

1.7

0.23

g/l

0.55

1456

6613

Other nutritional deficiencies

1478

8626

1.70

77.69

1.6

1.8

0.26

0.23

g/l

29.60

1405

8185

Osteoporosis with pathological fracture (FG)

162

323

5.29

77.39

2.3

1.2

0.23

0.24

g/l

0.96

150

302

Other antidepressants

2294

7738

1.57

77.24

1.7

0.24

0.23

g/l

4.01

2183

7331

Other diseases of upper respiratory tract

2415

8235

1.55

77.23

1.7

0.23

g/l

0.35

2276

7821

Mycoses

626

2837

2.27

76.60

1.8

1.7

0.23

g/l

0.67

596

2682

Disorders of sclera, cornea, iris and ciliary body

1204

6832

1.80

76.45

1.9

1.7

0.24

0.23

g/l

0.33

1133

6485

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2107

9221

1.57

76.36

1.7

0.24

0.23

g/l

2.18

1995

8747

Other arthrosis

968

3602

1.95

75.91

1.7

1.5

0.24

g/l

0.43

926

3404

Diseases of the myoneural junction and muscle

315

1027

3.21

75.80

2.6

1.5

0.22

0.24

g/l

2.80

304

970

Peripheral artery disease

792

3121

2.08

75.65

1.5

0.24

g/l

0.85

755

2929

Cystitis

1932

7437

1.61

75.57

1.9

1.7

0.23

g/l

0.25

1816

7065

Other noninfective gastroenteritis and colitis

602

2697

2.30

75.56

1.8

1.7

0.23

g/l

0.21

573

2561

Preparatory care for dialysis

170

365

5.13

75.53

2.0

1.5

0.26

0.24

g/l

1.51

162

347

Vasomotor and allergic rhinitis

923

4769

1.95

75.48

1.6

1.8

0.23

g/l

0.65

867

4553

Depression or dysthymia

1590

5326

1.69

74.41

1.8

1.7

0.23

g/l

0.16

1508

5060

Migraine without aura

557

2435

2.36

74.40

1.9

0.22

0.23

g/l

0.30

530

2321

Sleep apnoea

1947

8413

1.59

74.01

1.6

1.7

0.25

0.23

g/l

15.70

1858

7958

Other reaction to severe stress, and adjustment disorders

914

4834

1.93

73.13

2.1

1.8

0.23

g/l

0.51

868

4614

Hypertensive Renal Disease

122

198

6.65

72.95

1.5

1.3

0.27

0.23

g/l

3.61

116

190

Other diseases of hard tissues of teeth

1396

6151

1.72

72.80

1.9

1.6

0.23

g/l

1.25

1335

5827

Polyarthritis, unspecified

135

244

6.00

72.45

1.9

1.6

0.24

g/l

0.30

129

235

Hypermobility syndrome

196

484

4.35

72.39

1.8

1.2

0.22

0.24

g/l

1.62

183

449

Coxarthrosis [arthrosis of hip](FG)

828

2999

2.03

72.37

1.6

1.2

0.24

0.25

g/l

1.84

783

2830

5-aminosalicylic acid

441

1755

2.58

72.09

1.6

1.4

0.22

0.24

g/l

2.97

413

1673

Streptococcal septicaemia

217

577

3.95

71.79

2.2

1.5

0.25

0.24

g/l

1.43

201

549

Spondyloarthritis

414

1607

2.65

71.42

1.7

1.3

0.23

0.24

g/l

0.64

389

1518

Other anxiety disorders

1097

5450

1.82

71.41

1.8

0.23

g/l

0.21

1045

5194

Tumor necrosis factor alpha inhibitors

418

1638

2.66

71.40

1.6

1.8

0.22

0.23

g/l

1.07

389

1552

Disorders of other endocrine glands

984

5278

1.87

71.30

2.0

1.7

0.24

0.23

g/l

1.11

923

5004

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1279

7498

1.73

71.22

1.8

1.6

0.24

0.23

g/l

0.83

1199

7110

Haemolytic anaemias

147

297

5.47

70.22

3.4

1.5

0.19

0.24

g/l

7.83

133

282

Recurrent or chronic depression

977

3792

1.90

69.98

1.8

0.23

g/l

0.23

933

3610

Other and unspecified rosacea

272

857

3.37

69.83

2.3

1.8

0.22

0.23

g/l

1.30

254

810

Budesonide

300

995

3.12

69.71

1.6

1.4

0.22

0.24

g/l

1.57

280

944

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1101

6125

1.79

69.28

1.7

0.24

g/l

0.12

1025

5819

Atopic dermatitis, strict definition with reimbursement

736

3571

2.05

68.89

1.8

0.23

g/l

0.16

699

3413

Sleep apnoea, including avohilmo

2051

8708

1.55

68.74

1.6

1.7

0.25

0.23

g/l

19.28

1956

8237

Dysphagia

519

2278

2.34

68.44

1.7

1.5

0.23

g/l

0.74

489

2164

Early onset COPD, excluding more controls

376

1421

2.71

68.16

1.6

1.4

0.24

g/l

0.18

352

1343

Dizziness and giddiness

1561

7879

1.63

67.86

1.7

0.23

g/l

0.10

1470

7465

Hard cardiovascular diseases

1545

6090

1.65

67.63

1.7

1.6

0.24

g/l

2.19

1471

5767

Type 2 diabetes, wide definition

1593

6450

1.63

66.78

1.4

1.7

0.26

0.23

g/l

30.79

1509

6085

Other disorders of teeth and supporting structures

482

2073

2.39

66.75

1.9

1.5

0.23

0.24

g/l

0.51

458

1953

Atherosclerosis, excluding cerebral and coronary sclerosis

719

2843

2.06

66.72

1.5

0.24

g/l

0.42

681

2667

Other disorders of kidney and ureter

319

1129

2.95

66.41

1.8

1.5

0.26

0.24

g/l

2.51

301

1070

Fungal Sepsis

135

267

5.51

65.81

1.9

1.5

0.24

g/l

0.33

123

255

Other functional intestinal disorders

923

4814

1.86

65.42

1.8

1.6

0.23

g/l

0.44

871

4555

Follow-up examination after treatment for conditions other than malignant neoplasms

932

3287

1.89

64.78

1.8

1.6

0.23

0.24

g/l

1.00

871

3147

Other CVD (FINNGEN)

233

525

3.61

64.30

1.6

0.24

0.23

g/l

1.33

218

491

Sequelae of external causes of morbidity and mortality

558

2593

2.21

64.23

1.6

1.7

0.24

0.23

g/l

0.88

524

2447

Other disorders of white blood cells

182

469

4.16

63.50

1.9

1.5

0.22

0.24

g/l

1.80

168

441

Hyperlipidaemia, other/unspecified

709

3404

2.01

63.42

1.5

0.25

0.23

g/l

9.14

667

3211

Other bacterial intestinal infections

414

1707

2.50

63.14

1.8

1.6

0.23

0.24

g/l

0.81

376

1617

Cerebrovascular diseases

1399

6145

1.65

63.06

1.8

1.6

0.24

g/l

2.44

1329

5804

Lumbar disc prolapse

1298

6247

1.67

62.50

1.6

1.7

0.23

0.24

g/l

0.32

1226

5929

Pain in thoracic spine

374

1481

2.61

62.24

1.9

1.7

0.23

g/l

1.13

357

1408

Dentofacial anomalies [including malocclusion]

659

3266

2.04

61.78

1.8

1.7

0.23

g/l

0.66

625

3108

Somatoform disorder

428

1817

2.44

61.39

1.8

0.22

0.23

g/l

1.52

394

1721

Viral pneumonia

295

1044

2.93

61.23

2.1

1.5

0.24

g/l

0.30

281

994

COPD (mode)

496

1738

2.31

61.23

1.4

0.24

g/l

0.21

472

1631

Obesity and other hyperalimentation

1362

8385

1.63

61.21

1.6

1.8

0.26

0.23

g/l

37.54

1295

7954

Pure hypercholesterolaemia

1347

5511

1.66

61.14

1.5

1.6

0.25

0.23

g/l

12.49

1273

5223

Primary_lymphoid and hematopoietic malignant neoplasms

496

2243

2.27

60.96

1.7

1.5

0.24

g/l

0.03

457

2119

Symptoms and signs involving speech and voice

714

3709

1.97

60.51

1.8

1.7

0.23

g/l

0.84

673

3491

Obesity

1354

8356

1.63

60.44

1.6

1.8

0.26

0.23

g/l

37.86

1287

7926

Hypothyroidism, strict autoimmune, 3 medication purchases required

1830

8222

1.54

60.10

1.8

1.7

0.23

g/l

0.30

1721

7803

Bacterial intestinal infections, IBD co-morbidities

413

1741

2.45

60.02

1.8

1.6

0.23

0.24

g/l

0.82

376

1642

Paroxysmal tachycardia

454

1660

2.36

59.78

1.8

1.6

0.24

0.23

g/l

3.02

425

1563

Bronchiectasis

208

610

3.59

59.69

1.5

0.23

g/l

0.36

197

574

Subjective visual disturbances

562

2696

2.14

59.68

2.0

1.7

0.23

g/l

0.20

531

2538

Diverticular disease of intestine

1351

5510

1.65

59.61

1.6

0.24

g/l

0.09

1274

5213

Primary_lymphoid and hematopoietic malignant neoplasms

496

2268

2.25

59.42

1.7

1.5

0.24

g/l

0.03

457

2140

Disorders resulting from impaired renal tubular function

139

310

4.92

59.04

2.1

1.5

0.26

0.24

g/l

2.05

129

296

Hypertensive Heart Disease

390

1291

2.52

58.90

1.7

1.5

0.25

0.23

g/l

3.28

364

1221

Unspecified haematuria

782

3582

1.90

58.83

1.7

1.5

0.25

0.24

g/l

2.34

740

3380

Dermatitis due to substances taken internally

166

422

4.17

58.79

2.7

1.7

0.22

0.23

g/l

0.67

156

399

Implicit fungal Sepsis

124

252

5.37

58.67

1.9

1.4

0.24

0.23

g/l

0.43

112

240

Primary biliary cholangitis (PBC)

117

7.91

58.24

1.9

1.1

0.21

0.25

g/l

4.01

110

Allergic rhinitis

747

3949

1.92

58.17

1.6

1.9

0.23

g/l

0.11

704

3796

Enterocolitis due to Clostridium difficile

250

832

3.13

58.04

1.8

1.6

0.24

0.23

g/l

0.24

226

790

Any mental disorder

2407

8349

1.46

57.83

1.8

1.7

0.24

0.23

g/l

0.95

2282

7930

Rotator cuff syndrome

1162

5176

1.69

57.41

1.6

0.24

g/l

0.24

1100

4885

Other diseases of lip and oral mucosa

372

1527

2.52

57.39

1.9

1.5

0.23

0.24

g/l

1.96

360

1440

Disorders of synovium and tendon

1065

5673

1.72

57.35

1.7

1.6

0.23

g/l

0.16

1019

5371

Psychiatric diseases

2370

8211

1.46

57.34

1.8

1.7

0.24

0.23

g/l

0.84

2252

7794

Cutaneous abscess, furuncle and carbuncle

578

2844

2.08

57.25

1.9

1.7

0.24

0.23

g/l

0.99

545

2694

ILD-related respiratory insufficiency

111

209

5.80

57.22

2.3

1.4

0.23

0.24

g/l

0.35

104

200

350

1404

2.59

56.88

1.9

1.7

0.25

0.23

g/l

3.33

325

1335

Persons encountering health services in other circumstances

812

4493

1.84

56.15

1.8

1.7

0.23

g/l

0.06

785

4254

Rash and other nonspecific skin eruption

272

969

2.94

56.15

2.3

1.7

0.23

0.24

g/l

1.00

259

914

Insulin, combination of fast acting with intermediate-acting or long-acting

1177

6630

1.66

56.13

1.5

1.6

0.26

0.23

g/l

16.68

1114

6277

Convulsions, not elsewhere classified

447

1977

2.28

55.90

2.0

1.6

0.22

0.23

g/l

0.70

412

1879

Thyroiditis, ILD-related definition

290

1070

2.82

55.80

2.2

1.3

0.22

0.24

g/l

3.62

281

1007

Papulosquamous disorders

821

4575

1.83

55.73

1.6

1.7

0.25

0.23

g/l

4.29

782

4328

Benign neoplasm of colon, rectum, anus and anal canal

1125

6148

1.68

55.49

1.6

0.24

g/l

0.25

1065

5798

Hyperkalaemia

141

333

4.47

55.01

1.5

1.3

0.25

0.23

g/l

1.57

128

322

Other viral diseases

690

3649

1.93

54.97

2.0

1.8

0.23

g/l

0.11

653

3478

Ischaemic heart disease, wide definition

1447

5755

1.59

54.91

1.7

1.6

0.24

g/l

2.96

1381

5440

Chronic gastritis

546

2669

2.09

54.90

1.8

1.5

0.23

0.24

g/l

2.18

515

2518

Reactive arthropathies, FINNGEN

175

483

3.78

54.88

2.7

1.2

0.23

0.25

g/l

1.57

168

457

Gonarthrosis

1126

3834

1.70

54.72

1.6

1.5

0.24

g/l

0.75

1065

3624

Other gastritis (incl. Duodenitis)

472

2187

2.21

54.70

1.6

0.23

0.24

g/l

0.33

444

2071

Insulin, fast-acting

750

4086

1.87

54.65

1.4

1.7

0.25

0.23

g/l

7.07

710

3878

Peripheral artery operations in Hilmo

250

861

2.99

54.35

1.6

1.4

0.24

g/l

0.01

238

814

Diagnoses used for exclusion with ILD

522

2522

2.12

54.25

1.6

0.23

0.24

g/l

0.48

502

2383

Obesity due to excess calories

1014

6044

1.71

54.23

1.5

1.8

0.26

0.23

g/l

31.34

970

5742

Insulin medication

1177

6191

1.65

54.06

1.5

1.7

0.26

0.23

g/l

20.87

1114

5870

Migraine, single triptan purchase ok & required. ICD-code if available is included

1730

7800

1.52

54.04

1.8

0.23

g/l

1.99

1646

7414

Triptan medication for migraine, single purchase ok

1730

7800

1.52

54.04

1.8

0.23

g/l

1.99

1646

7414

Anaemia in chronic diseases classified elsewhere

178

6.17

53.86

2.1

1.4

0.25

0.23

g/l

1.47

169

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1163

7185

1.64

53.79

1.8

1.7

0.24

0.23

g/l

0.59

1088

6799

Inflammatory diseases of the central nervous system

234

786

3.12

53.77

3.5

1.6

0.22

0.23

g/l

2.07

218

743

Diseases of oral cavity, salivary glands and jaws

1870

6419

1.51

53.75

1.8

1.6

0.23

g/l

0.08

1775

6075

Cardiomyopathy

332

1337

2.55

53.16

1.4

0.23

0.24

g/l

0.54

310

1260

Juvenile arthritis (FINNGEN)

149

377

4.18

53.13

2.6

1.2

0.20

0.23

g/l

3.99

144

350

Benign neoplasm: Colon

946

5454

1.73

52.67

1.6

1.5

0.24

g/l

0.16

894

5137

Other respiratory disorders and diseases

395

1729

2.34

52.58

1.6

1.5

0.24

g/l

0.63

367

1635

Other diseases of the respiratory system

395

1729

2.34

52.58

1.6

1.5

0.24

g/l

0.63

367

1635

Disorders of lens

1294

5107

1.62

52.54

1.8

1.6

0.24

g/l

0.06

1214

4827

Voice disturbances

587

2998

2.01

52.47

1.8

1.7

0.23

g/l

1.37

556

2827

Adalimumab

264

961

2.88

52.46

1.5

1.7

0.22

0.23

g/l

1.01

246

904

Insulin, intermediate and long-acting

1035

6128

1.68

52.34

1.4

1.6

0.26

0.23

g/l

16.25

979

5802

Fibrosis and cirrhosis of liver

195

600

3.42

52.00

1.5

0.20

0.24

g/l

5.24

181

571

Pain and other conditions associated with female genital organs and menstrual cycle

531

2517

2.08

51.73

1.9

1.8

0.22

0.23

g/l

0.39

499

2382

Idiopathic thrombocytopenic purpura

122

273

4.90

51.65

4.0

1.5

0.19

0.24

g/l

6.60

112

261

Other enthesopathies

614

3196

1.96

51.65

1.7

1.6

0.24

0.23

g/l

0.69

589

3019

Other neurological diseases

1358

7014

1.58

51.52

1.7

1.6

0.23

g/l

0.28

1278

6633

Triptan medication for migraine, min. 3 purchases

1309

6586

1.59

51.43

1.8

1.9

0.22

0.23

g/l

2.43

1249

6272

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1200

7430

1.61

51.27

1.9

1.7

0.23

g/l

0.76

1136

7043

Amputation

208

668

3.23

51.27

1.6

1.4

0.24

g/l

0.14

195

628

Reactive arthropathies

211

685

3.20

51.16

2.6

1.5

0.23

0.24

g/l

1.28

200

646

Benign neoplasm of colon, rectum, anus and anal canal

1071

4629

1.68

51.04

1.6

0.24

g/l

0.06

1019

4390

Ischemic heart diseases

1454

5900

1.56

50.76

1.7

1.6

0.24

g/l

3.01

1389

5577

Allergic urticaria

234

818

3.00

50.10

2.0

1.9

0.24

0.23

g/l

1.06

224

770

Benign neoplasm: Colon

934

4212

1.73

50.07

1.6

0.24

g/l

0.11

883

3995

Insulin, fast-acting or short human

752

4212

1.82

50.06

1.4

1.7

0.25

0.23

g/l

6.32

712

3997

Candidiasis

336

1406

2.48

49.98

1.8

0.23

g/l

0.39

318

1323

Myocarditis

124

285

4.56

49.95

2.1

1.6

0.23

g/l

0.30

117

269

Cervicobrachial syndrome

483

2340

2.11

49.92

1.6

1.8

0.23

0.24

g/l

0.85

454

2214

Temporomandibular joint disorders, including avohilmo

967

5813

1.69

49.89

1.9

1.8

0.23

g/l

1.02

918

5525

Inflammatory bowel disease

703

3868

1.86

49.88

1.5

1.7

0.23

g/l

0.66

662

3680

Drug-induced osteoporosis with pathological fracture

127

7.29

49.82

2.6

1.4

0.24

0.23

g/l

0.35

119

Other diseases of arteries and capillaries

210

695

3.14

49.35

1.7

1.6

0.23

0.24

g/l

0.47

193

657

Iridocyclitis

497

2451

2.08

49.05

1.9

1.7

0.24

g/l

0.03

474

2327

Chronic periodontitis

324

1347

2.48

48.70

2.1

1.5

0.24

g/l

0.17

311

1263

Allergic conjunctivitis

1250

7922

1.58

48.59

1.9

1.8

0.23

g/l

0.61

1182

7511

Other or ill-defined heart diseases

138

354

4.09

48.13

1.9

1.5

0.23

0.24

g/l

0.29

128

333

Other encephalitis

112

248

4.96

48.08

4.8

1.5

0.20

0.24

g/l

3.26

104

240

Internal derangement of knee

673

3679

1.85

48.03

1.7

1.6

0.24

g/l

0.24

640

3485

Noninfectious colitis NAS

321

1342

2.47

47.75

2.0

1.7

0.23

g/l

0.05

313

1273

Diaphragmatic hernia

698

3883

1.83

47.73

1.9

1.6

0.24

g/l

0.03

656

3668

Other diseases of liver

402

1850

2.24

47.70

1.8

1.6

0.24

g/l

0.21

378

1750

Migraine without aura and triptan purchases

427

2016

2.18

47.55

1.9

2.0

0.22

0.23

g/l

0.41

407

1920

Concussion

936

4858

1.69

47.53

1.8

1.7

0.23

g/l

0.44

881

4611

Other complications of surgical and medical care, not elsewhere classified

254

954

2.77

47.43

1.7

0.24

0.23

g/l

0.28

242

902

Later onset COPD, excluding more controls

304

944

2.56

47.06

1.3

0.24

g/l

0.41

291

873

Soft tissue disorders related to use, overuse and pressure

507

2555

2.03

46.93

1.9

1.6

0.23

g/l

0.13

472

2401

Oxicams

494

1340

2.13

46.84

1.8

1.7

0.23

g/l

0.26

474

1266

L04AC Interleukin inhibitors

164

487

3.59

46.58

1.6

0.23

0.24

g/l

0.57

159

460

Phlebitis and thrombophlebitis (not including DVT)

472

2328

2.08

46.58

1.9

1.6

0.24

g/l

0.46

444

2202

Cervical disc disorders

698

3910

1.82

46.54

1.5

1.6

0.24

g/l

0.01

660

3707

Spinal stenosis

876

4053

1.72

46.50

1.5

0.24

g/l

0.05

827

3813

Respiratory insufficiency

145

393

3.80

46.38

1.6

1.3

0.25

0.24

g/l

1.23

132

367

Functional dyspepsia

559

2931

1.95

46.20

1.7

1.6

0.24

0.23

g/l

0.24

528

2778

Coeliac disease

313

1315

2.47

46.19

2.3

1.8

0.21

0.23

g/l

5.33

296

1251

Coxibs

578

1556

2.01

46.07

1.6

1.8

0.23

g/l

0.05

542

1475

Intracranial trauma

1082

5038

1.62

46.05

1.8

1.7

0.23

g/l

1.01

1018

4779

Encephalitis

115

271

4.63

45.62

4.7

1.5

0.20

0.24

g/l

3.58

107

260

Cellulitis

454

2226

2.09

45.54

2.1

1.6

0.24

0.23

g/l

1.57

433

2106

Crohn disease

329

1424

2.39

45.34

1.6

1.8

0.23

g/l

0.07

312

1352

Pruritus

255

983

2.69

45.10

2.1

1.8

0.22

0.23

g/l

0.89

241

928

Sequelae of other external causes

158

467

3.58

45.07

1.5

1.6

0.24

g/l

0.29

148

442

Childhood asthma (age<16), excluding more controls

299

960

2.53

45.05

1.9

0.22

g/l

0.06

278

929

Factors influencing health status and contact with health services

600

1545

1.97

45.03

1.5

0.24

g/l

0.14

569

1478

Dermatopolymyositis, unspecified

14.64

44.92

1.9

1.1

0.21

0.25

g/l

1.86

Collagenous colitis

226

823

2.87

44.88

2.0

1.7

0.24

0.23

g/l

0.08

213

781

COPD

743

3503

1.78

44.70

1.5

1.6

0.24

g/l

0.39

701

3277

Cervicalgia

421

2021

2.13

44.63

1.7

0.23

0.24

g/l

0.87

400

1907

Childhood asthma (age<16)

299

965

2.51

44.61

1.9

0.22

g/l

0.08

278

934

Meniscus derangement

940

3886

1.67

44.54

1.6

1.5

0.24

g/l

0.20

897

3668

Small fibre neuropathy

107

244

4.83

44.38

2.3

1.4

0.23

0.24

g/l

0.74

102

234

Scleritis and episcleritis

185

609

3.21

44.30

2.0

1.7

0.25

0.23

g/l

1.06

171

574

Disorders of parathyroid gland

405

1901

2.16

44.00

2.1

1.5

0.24

0.23

g/l

0.28

374

1785

Carpal tunnel syndrome

1192

6995

1.56

43.83

1.6

1.7

0.23

g/l

0.01

1149

6614

Glucagon-like peptide-1 (GLP-1) analogues

978

4979

1.64

43.78

1.4

1.6

0.26

0.23

g/l

21.85

923

4699

Hypo-osmolality and hyponatraemia

319

1378

2.37

43.57

1.8

1.5

0.22

0.23

g/l

2.23

299

1296

Amputation of toe

159

483

3.44

43.22

1.6

1.3

0.23

0.24

g/l

0.39

152

461

Benign neoplasms

2043

8136

1.41

42.95

1.8

1.7

0.23

g/l

0.30

1931

7757

Acute generalized exanthematous pustulosis

143

410

3.72

42.89

2.8

1.6

0.23

0.24

g/l

0.29

133

390

Psoriatic arthropathies

221

813

2.81

42.78

1.5

0.24

g/l

0.31

212

767

Peripheral arterial reconstruction

293

1233

2.44

42.77

1.4

0.25

0.24

g/l

1.23

279

1162

Constipation

1694

8448

1.45

42.70

1.7

1.6

0.23

g/l

0.61

1589

8019

Unspecified privation

256

1017

2.61

42.64

1.7

1.6

0.23

g/l

0.07

244

962

Disorders of muscles

229

862

2.75

42.44

1.7

1.6

0.23

0.24

g/l

0.03

223

809

Idiopathic gout

187

632

3.08

42.43

1.5

1.3

0.27

0.24

g/l

2.33

181

597

Inflammatory diseases of female pelvic organs

1363

6884

1.51

42.42

1.9

0.23

g/l

0.17

1275

6531

Stroke, excluding SAH

1023

4778

1.61

42.17

1.7

1.5

0.24

g/l

1.23

968

4499

Diseases of the ear and mastoid process

2488

9280

1.37

42.09

1.8

1.7

0.23

g/l

0.70

2363

8806

Use of hypnotics and sedatives

2159

9036

1.39

42.01

1.7

0.23

0.24

g/l

0.50

2052

8565

Drug-induced cataract

222

4.93

42.00

2.6

1.5

0.22

0.24

g/l

1.00

209

Coxarthrosis

779

3083

1.73

41.94

1.7

1.5

0.24

g/l

0.10

736

2919

Disorders of mineral metabolism

193

671

3.00

41.72

1.7

1.6

0.24

g/l

0.64

179

642

Other viral diseases, not elsewhere classified

434

2160

2.06

41.60

2.1

1.8

0.22

0.23

g/l

0.55

410

2056

Abnormal weight loss

205

742

2.88

41.16

2.1

1.5

0.23

g/l

0.43

196

706

GI-bleeding

549

2970

1.88

41.06

1.6

1.5

0.24

g/l

0.15

513

2795

Stroke, including SAH

1087

5161

1.58

41.05

1.7

1.5

0.24

g/l

1.27

1026

4868

Abnormal results of function studies

212

785

2.81

40.77

1.8

1.6

0.23

0.24

g/l

1.08

202

742

Missing teeth due to accident, extraction or parodontitis

260

1063

2.53

40.72

2.1

1.5

0.22

0.24

g/l

2.44

248

998

Agranulocytosis

264

1089

2.52

40.67

2.6

1.6

0.20

0.24

g/l

6.49

246

1035

Erythema multiforme

203

5.02

40.66

2.6

1.4

0.21

0.23

g/l

1.63

195

Gingivitis and periodontal diseases

1762

6369

1.44

40.46

1.7

1.6

0.23

g/l

0.29

1674

6027

Deforming dorsopathies

552

3009

1.87

40.42

1.7

0.23

g/l

0.78

514

2850

Weight loss

222

845

2.73

40.41

2.0

1.6

0.23

g/l

0.42

212

803

Pollen allergy

468

2399

1.98

40.27

1.6

1.9

0.22

g/l

0.36

440

2291

Hernia of abdominal wall, postoperative

310

1375

2.30

40.04

1.5

0.25

0.24

g/l

0.85

283

1326

Statin medication

1470

5618

1.48

39.67

1.8

1.7

0.25

0.23

g/l

21.50

1401

5321

Other embolism and thrombosis

277

1180

2.42

39.57

2.2

1.6

0.24

g/l

0.05

264

1114

Atopic dermatitis, strict definition

694

3990

1.74

39.55

1.8

1.9

0.23

g/l

0.01

658

3810

Anterior Iridocyclitis

439

2241

2.01

39.47

1.9

1.7

0.23

0.24

g/l

0.27

417

2123

Other disorders of veins

767

4626

1.68

39.28

1.6

1.7

0.23

0.24

g/l

0.28

730

4372

Sarcoidosis

304

1357

2.31

39.04

1.6

0.23

0.24

g/l

0.63

292

1283

Disorders of choroid and retina

1435

7178

1.47

39.02

1.7

1.6

0.24

g/l

0.91

1367

6786

Selective serotonin reuptake inhibitors

2045

7801

1.39

38.79

1.7

0.24

0.23

g/l

2.23

1936

7393

Diabetic retinopathy, excluding more controls

478

1366

2.02

38.78

1.4

1.5

0.26

0.25

g/l

1.54

458

1307

Coronary atherosclerosis

1169

4952

1.54

38.74

1.7

1.5

0.24

g/l

1.57

1111

4677

Other disorders of patella

343

1608

2.18

38.72

1.8

1.6

0.23

0.24

g/l

0.55

323

1520

Stomatitis and related lesions

203

755

2.79

38.66

2.1

1.6

0.23

g/l

0.26

189

713

Other infectious diseases

182

640

2.96

38.55

2.1

1.5

0.24

g/l

0.04

169

606

Acute and subacute iridocyclitis

411

2068

2.04

38.52

1.8

1.7

0.23

0.24

g/l

0.16

390

1960

Other chronic obstructive pulmonary disease

692

3366

1.73

38.49

1.4

1.6

0.24

g/l

0.61

653

3153

Suggestive for eosinophilic asthma

209

793

2.73

38.28

1.5

1.6

0.24

g/l

0.18

203

749

Ischaemic Stroke, excluding all haemorrhages

938

4474

1.60

38.25

1.7

1.5

0.24

g/l

1.67

884

4208

Non-selective monoamine reuptake inhibitors

744

4349

1.68

38.09

1.6

1.7

0.24

0.23

g/l

1.36

701

4103

Other diseases of the digestive system

542

2995

1.84

37.93

1.6

1.5

0.24

g/l

0.03

507

2820

Other external causes of accidental injury

1791

6373

1.42

37.78

1.8

1.7

0.24

0.23

g/l

2.82

1696

6072

Deposits [accretions] on teeth

184

635

2.92

37.62

2.3

1.5

0.24

0.23

g/l

0.55

174

604

Senile cataract

1095

4422

1.55

37.51

1.7

1.5

0.24

g/l

0.12

1029

4179

Exposure to other specified factors

1459

9579

1.44

37.31

1.9

1.7

0.23

g/l

0.00

1388

9093

Volume depletion

178

629

2.92

37.20

1.5

0.25

0.23

g/l

1.50

166

596

Other retinal disorders

1081

5709

1.54

37.14

1.7

1.6

0.24

g/l

1.13

1025

5377

Benign neoplasms

1664

6655

1.43

37.09

1.8

0.23

g/l

0.22

1567

6363

Osteomyelitis

154

505

3.19

37.02

1.7

1.4

0.24

g/l

0.22

149

484

Monoarthritis, not elsewhere classified

108

282

4.02

36.90

1.3

1.5

0.23

0.24

g/l

0.52

101

268

Other skin changes

335

1590

2.16

36.83

1.9

1.6

0.23

0.24

g/l

1.07

319

1495

Accidents

1784

6373

1.41

36.82

1.8

1.7

0.24

0.23

g/l

3.15

1691

6072

Other dermatomyositis

12.65

36.79

1.5

1.1

0.19

0.25

g/l

2.44

Other symptoms and signs involving the circulatory and respiratory systems

147

471

3.24

36.61

2.0

1.5

0.23

g/l

0.03

135

449

Conjunctivitis (acute, non atopic)

579

3293

1.79

36.52

1.9

1.7

0.23

g/l

0.02

549

3139

Disorders of calcium metabolism

151

494

3.20

36.46

1.7

1.6

0.24

0.23

g/l

0.73

140

472

Generalized skin eruption due to drugs and medicaments

124

361

3.66

36.42

2.9

1.6

0.23

0.24

g/l

0.51

114

344

Diplopia

278

1232

2.33

36.33

1.7

1.6

0.23

0.24

g/l

0.92

266

1160

Falls/tendency to fall

2349

8798

1.35

36.14

1.8

1.7

0.24

0.23

g/l

2.21

2226

8362

Hallux valgus (acquired)

571

2314

1.81

36.11

1.7

1.5

0.23

0.24

g/l

2.90

540

2178

Exclusions for E4_PCOS_BROAD

383

1924

2.04

36.11

1.7

0.23

g/l

0.23

363

1826

Disorders of gallbladder, biliary tract and pancreas

1904

8954

1.38

36.05

1.7

0.24

0.23

g/l

5.48

1797

8487

Fall on same level

2366

9937

1.34

35.95

1.8

1.7

0.24

0.23

g/l

2.49

2237

9442

Other inflammation of eyelid

284

1276

2.29

35.93

2.2

1.6

0.22

0.24

g/l

2.76

263

1205

Direct fill therapy

314

1471

2.20

35.82

2.0

1.6

0.23

g/l

0.10

293

1391

Sequelae with surgical and medical care as external cause

393

2003

2.01

35.57

1.6

0.24

g/l

0.33

369

1888

Chronic diseases of tonsils and adenoids

1607

7228

1.42

35.56

1.7

0.23

g/l

1.49

1529

6882

Abnormalities of gait and mobility

239

1002

2.46

35.49

1.6

1.5

0.24

g/l

0.01

229

948

Paracetamol of NSAID medication

366

860

2.17

35.47

1.5

1.8

0.24

0.22

g/l

2.65

350

819

Ulcerative colitis, NAS

318

1504

2.17

35.36

1.6

1.7

0.22

0.24

g/l

2.72

298

1428

Other symptoms and signs involving cognitive functions and awareness

752

4346

1.64

35.10

1.7

1.6

0.23

g/l

1.05

693

4113

Conduction disorders

474

2123

1.88

34.87

1.5

0.23

0.24

g/l

0.39

441

1990

Unspecified acute lower respiratory infection

305

1429

2.19

34.67

1.7

1.6

0.24

g/l

0.02

290

1358

Benzodiazepine use

1953

10275

1.36

34.64

1.7

0.23

g/l

0.27

1845

9750

Other cataract

749

3555

1.65

34.62

1.9

1.5

0.24

g/l

0.01

709

3344

Recurring oral aphthae, including avohilmo

304

1429

2.19

34.42

2.1

1.7

0.22

0.23

g/l

1.47

288

1350

IBD patients in KELA-register

486

2682

1.85

34.39

1.6

1.8

0.23

g/l

1.16

461

2558

Presence of other functional implants

961

4416

1.56

34.35

1.6

1.5

0.24

g/l

0.11

906

4143

Psoriasis

549

3142

1.78

34.32

1.6

1.7

0.26

0.23

g/l

5.70

525

2971

COPD, hospital admission 2, with asthma infections

504

2384

1.83

34.02

1.4

1.5

0.24

g/l

0.48

470

2250

External causes of morbidity and mortality

1436

5011

1.45

33.85

1.8

1.7

0.24

0.23

g/l

2.30

1356

4789

Adrenocortical insufficiency

116

340

3.65

33.82

1.6

0.25

0.24

g/l

0.49

105

323

Hypokalaemia

231

976

2.44

33.69

1.5

1.6

0.24

0.23

g/l

0.25

215

927

Enthesopathies of lower limb, excluding foot

429

2294

1.91

33.54

1.6

1.7

0.23

0.24

g/l

0.09

402

2179

Herpesviral [herpes simplex] infections

266

1199

2.29

33.47

2.0

1.6

0.23

g/l

0.45

250

1128

Other disorders of adrenal gland

134

432

3.28

33.42

1.5

1.6

0.24

0.23

g/l

0.54

123

412

Allergic contact dermatitis

295

1387

2.18

33.31

1.5

1.7

0.24

0.23

g/l

0.69

278

1318

Adjustment and management of implanted device

311

1490

2.13

33.28

1.4

1.5

0.24

0.23

g/l

0.45

288

1409

Obesity, other/unspecified

699

4314

1.65

32.95

1.6

1.8

0.26

0.23

g/l

17.81

658

4114

Viral warts

230

983

2.42

32.81

2.7

1.7

0.21

0.23

g/l

2.23

223

925

Trochanteric bursitis

270

1233

2.25

32.78

1.8

1.6

0.24

0.23

g/l

0.32

253

1158

Ulcerative colitis

499

2816

1.81

32.78

1.5

1.7

0.23

0.24

g/l

1.18

466

2681

Irregular menses

1061

5814

1.50

32.36

2.1

1.9

0.23

g/l

0.03

1007

5514

Other disorders of eye and adnexa

313

1527

2.11

32.17

1.8

0.24

0.23

g/l

0.36

298

1444

Lichen simplex chronicus and prurigo

144

493

3.04

32.12

1.5

1.7

0.24

g/l

0.10

134

472

Ocular pain

201

818

2.55

32.06

1.8

0.23

g/l

0.16

192

771

Ovarian cyst

843

3099

1.60

31.97

1.8

0.23

g/l

0.09

801

2928

Other shoulder lesions

202

823

2.53

31.96

1.8

1.7

0.24

0.23

g/l

0.24

190

772

Crohn's disease NAS

171

645

2.76

31.90

1.7

0.24

0.23

g/l

0.50

162

609

Neoplasms

1634

6330

1.40

31.76

1.8

0.23

g/l

0.69

1549

6061

Correction of physiology of bite - demanding therapy visit

192

770

2.60

31.69

2.0

1.8

0.21

0.23

g/l

2.11

183

723

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

107

310

3.66

31.68

2.3

1.5

0.22

0.24

g/l

1.88

100

291

Dental pulpitis 1

2195

8626

1.33

31.61

1.7

0.24

0.23

g/l

2.16

2086

8177

All influenza (not pneumonia)

289

1374

2.15

31.60

1.8

1.6

0.22

0.24

g/l

1.40

269

1308

Diseases of pulp and periapical tissues, including avohilmo

2191

8610

1.33

31.53

1.7

0.24

0.23

g/l

2.32

2082

8162

Dental pulpitis 4

2194

8623

1.33

31.53

1.7

0.24

0.23

g/l

2.04

2085

8174

Inflammatory bowel disease, strict (require KELA)

486

2755

1.80

31.50

1.6

1.7

0.23

g/l

1.10

461

2622

Presence of cardiac and vascular implants and grafts

699

3262

1.64

31.45

1.6

1.5

0.24

g/l

0.14

654

3061

Cardiomyopathies, Primary/intrinsic

211

888

2.43

30.97

1.4

0.24

g/l

0.23

192

836

Other erythematous conditions

101

287

3.74

30.80

2.0

1.6

0.24

g/l

0.15

274

Keratitis

654

4043

1.64

30.60

1.9

1.7

0.23

g/l

0.04

615

3837

TMD related operations

369

1947

1.94

30.31

2.1

1.8

0.22

0.23

g/l

4.03

350

1846

Sequelae of cerebrovascular disease

543

2801

1.73

30.17

1.9

1.5

0.24

g/l

0.01

513

2634

Other metabolic disorders

291

1416

2.11

30.14

1.6

1.8

0.24

0.23

g/l

1.62

272

1345

Other disorders of bone

411

2248

1.87

30.06

1.7

0.24

0.23

g/l

0.17

387

2133

Other inflammatory liver diseases

157

585

2.79

29.99

2.1

1.6

0.21

0.24

g/l

3.29

146

553

Cardiomyopathy (excluding other)

214

922

2.37

29.80

1.4

1.5

0.24

g/l

0.34

195

871

Valvular operations

231

1028

2.29

29.79

1.7

1.4

0.23

0.24

g/l

0.29

218

965

Other and unspecified erythematous conditions

263

3.81

29.39

2.1

1.6

0.24

g/l

0.22

252

Heart failure and coronary heart disease

480

2030

1.79

29.37

1.5

1.4

0.24

g/l

0.69

454

1905

Hyperparathyroidism

320

1609

2.01

29.07

2.0

1.5

0.24

0.23

g/l

0.65

293

1509

AV-block

252

1057

2.20

29.05

1.4

0.24

g/l

0.40

231

988

Hypotension

256

1203

2.17

28.87

1.6

1.4

0.24

g/l

0.33

239

1133

Cardiomyopathy, other and unspecified

151

561

2.78

28.86

1.5

0.23

0.24

g/l

0.58

138

530

Other and unspecified disorders of skin and subcutaneous tissue

142

513

2.87

28.75

2.2

1.5

0.22

0.24

g/l

1.28

135

488

Episcleritis

145

533

2.85

28.59

2.0

1.7

0.25

0.24

g/l

1.07

135

500

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

117

383

3.24

28.57

1.7

1.6

0.24

0.23

g/l

0.19

103

361

Nonorganic sleeping disorders, excluding more controls

362

1933

1.91

28.56

1.9

1.7

0.23

g/l

0.12

342

1841

DVT of lower extremities

340

1779

1.95

28.53

1.9

1.6

0.24

g/l

0.51

320

1677

Localized swelling, mass and lump of skin and subcutaneous tissue

564

3424

1.67

28.43

1.8

1.7

0.23

0.24

g/l

2.00

541

3242

Sacroiliitis, not elsewhere classified

128

441

3.03

28.34

1.6

1.8

0.24

0.23

g/l

0.23

119

412

Recurring oral aphthae

126

432

3.07

28.27

2.1

1.6

0.23

g/l

0.06

121

410

Drug-induced adrenocortical insufficiency

177

4.56

28.21

1.7

1.5

0.25

0.24

g/l

0.37

171

Injuries to the ankle and foot

1360

8999

1.39

28.17

1.9

1.7

0.24

0.23

g/l

1.24

1292

8547

Other diseases of anus and rectum

502

2962

1.72

28.04

1.8

1.6

0.23

0.24

g/l

0.31

472

2787

Type 1 diabetes

503

2970

1.72

28.04

1.6

1.8

0.24

0.23

g/l

4.95

471

2825

Crohn's disease of small intestine

173

701

2.56

27.92

1.7

1.8

0.23

g/l

0.35

166

664

Chronic periodontitis, complicated

197

846

2.41

27.90

1.9

1.5

0.25

0.24

g/l

0.68

190

803

Other Crohn's disease

174

708

2.55

27.82

1.7

0.24

0.23

g/l

0.49

165

668

Hereditary angioödema type 1

43.75

27.80

2.9

1.3

0.14

0.25

g/l

—

Other diseases of intestine

226

1031

2.25

27.60

1.7

1.6

0.24

g/l

0.22

214

976

Other chronic obstructive pulmonary disease, including avohilmo

834

4611

1.52

27.54

1.5

0.24

g/l

0.36

788

4347

Excessive attrition of teeth

787

2761

1.57

27.43

1.8

1.7

0.22

0.23

g/l

0.97

755

2627

Behavioural syndromes associated with physiological disturbances and physical factors

655

4162

1.60

27.36

1.9

1.8

0.23

g/l

0.45

626

3974

Systemic disorders of connective tissue in diseases classified elsewhere

11.74

27.22

1.5

1.2

0.22

0.23

g/l

0.19

Other and unspecified myopathies

162

643

2.60

27.18

1.3

1.4

0.24

g/l

0.09

154

612

Fenamates

307

1036

2.03

27.10

1.7

1.9

0.23

g/l

0.28

293

981

Nonalcoholic fatty liver disease

204

901

2.34

27.10

1.8

1.6

0.24

g/l

0.09

192

855

COPD, hospital admissions

692

3754

1.58

27.08

1.4

1.5

0.24

g/l

0.34

652

3529

Other and unspecified disorders of white blood cells

109

353

3.25

27.02

2.2

1.5

0.21

0.24

g/l

1.79

333

Benign neoplasm of other and ill-defined parts of digestive system

329

1737

1.94

26.98

1.5

1.6

0.24

0.23

g/l

0.38

309

1635

Etanercept

158

625

2.63

26.88

1.6

1.7

0.22

0.23

g/l

1.06

145

587

COPD, early/later onset

696

3778

1.57

26.86

1.4

1.5

0.24

g/l

0.37

656

3552

Other CVD

297

1515

2.00

26.82

1.6

1.4

0.24

g/l

0.80

278

1425

Multiple myeloma, excluding all cancers (controls excluding all cancers)

103

324

3.32

26.69

1.8

1.5

0.24

0.23

g/l

0.27

310

Non-invasive ventilation

356

1808

1.88

26.63

1.4

1.7

0.25

0.23

g/l

6.07

309

1721

Cerebral palsy and other paralytic syndromes

237

1120

2.17

26.56

2.0

1.6

0.24

0.23

g/l

0.39

221

1060

Other enthesopathy of foot (+metatarsalgia)

205

914

2.30

26.53

2.0

1.7

0.23

g/l

0.33

196

856

Diabetes mellitus

1987

9111

1.31

26.39

1.5

1.8

0.25

0.23

g/l

34.03

1886

8634

Diabetes, varying definitions

1975

9062

1.31

26.35

1.5

1.8

0.25

0.23

g/l

33.72

1875

8589

Other/unspecified reactive arthropathies

160

643

2.59

26.32

2.7

1.7

0.23

0.24

g/l

0.52

153

609

Erythema nodosum

254

3.67

26.27

1.9

1.6

0.24

g/l

0.03

242

Bullous disorders

127

455

2.91

26.21

1.8

1.5

0.22

0.23

g/l

1.03

121

431

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

240

1148

2.14

26.02

1.7

1.5

0.23

0.24

g/l

0.71

222

1085

Injury, poisoning and certain other consequences of external causes

1145

4030

1.44

25.99

1.8

1.7

0.23

g/l

0.66

1086

3842

Excessive, frequent and irregular menstruation

870

3244

1.51

25.84

2.1

1.8

0.23

g/l

0.25

822

3069

Transient ischemic attack

819

4557

1.51

25.82

1.7

1.5

0.23

0.24

g/l

0.07

770

4288

Diseases of tongue

140

532

2.73

25.76

2.0

1.6

0.23

0.24

g/l

0.76

130

502

Persons encountering health services for specific procedures, not carried out

169

703

2.48

25.73

1.6

1.7

0.24

0.23

g/l

0.58

155

661

Misadventures to patients during surgical and medical care

276

1397

2.02

25.69

1.8

1.7

0.25

0.23

g/l

2.03

253

1318

Myocardial infarction, without ST-elevation

567

3252

1.63

25.62

1.6

1.5

0.24

g/l

0.74

536

3054

Gastroduodenal ulcer

399

2261

1.79

25.62

1.6

1.5

0.24

g/l

0.11

368

2140

Special screening examination for infectious and parasitic diseases

456

1984

1.74

25.58

1.9

1.7

0.22

0.24

g/l

2.07

430

1909

Endometriosis

768

3000

1.54

25.53

1.7

1.8

0.23

g/l

0.24

728

2835

Benign neoplasm of other and ill-defined parts of digestive system

329

1771

1.90

25.46

1.5

1.6

0.24

g/l

0.09

309

1661

Polyuria

383

2161

1.80

25.32

1.9

1.6

0.23

0.24

g/l

0.86

359

2049

Algoneurodystrophy

101

326

3.28

25.28

1.5

1.6

0.23

0.24

g/l

0.29

305

Oter anti-inflammatory and antirheumatic agents, non-steroids

390

1184

1.85

25.25

1.6

1.7

0.23

g/l

0.20

365

1118

Other diseases of blood and blood-forming organs

146

574

2.64

25.11

1.8

1.5

0.24

g/l

0.03

133

543

Pacemaker

469

2722

1.70

25.07

1.4

1.5

0.23

0.24

g/l

0.31

431

2551

Injuries to the knee and lower leg

2297

10352

1.28

25.07

1.7

0.24

0.23

g/l

2.73

2190

9803

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1798

8388

1.32

25.06

1.4

1.7

0.26

0.23

g/l

33.86

1708

7950

Brachial plexus disorders

218

1022

2.20

25.05

1.5

1.8

0.23

g/l

0.23

213

961

Metatarsalgia

191

849

2.31

24.94

2.0

1.7

0.23

g/l

0.29

182

793

COPD, hospital admissions 3, with asthma pneumonia sepsis

395

1904

1.79

24.94

1.4

0.24

g/l

0.42

366

1793

Pneumonia due to other infectious organisms, not elsewhere classified

249

3.60

24.78

2.1

1.5

0.24

g/l

0.15

237

Other specified/unspecified soft tissue disorders

109

370

3.06

24.77

2.0

1.6

0.24

0.23

g/l

0.61

104

346

COPD related to multimorbidity

573

3032

1.61

24.45

1.4

1.5

0.24

g/l

0.84

538

2858

Cytomegaloviral disease

229

3.76

24.39

2.2

1.5

0.25

0.23

g/l

0.76

218

Postprocedural endocrine and metabolic disorders, not elsewhere classified

260

1314

2.03

24.37

1.6

1.8

0.24

0.23

g/l

1.62

242

1247

Myocardial infarction

770

3691

1.51

24.37

1.6

1.5

0.24

0.23

g/l

2.23

729

3471

Protozoal diseases

244

3.63

24.21

2.0

1.4

0.23

g/l

0.07

232

Multiple myeloma and malignant plasma cell neoplasms

323

3.20

24.17

1.8

1.5

0.24

0.23

g/l

0.38

309

Chronic laryngitis and laryngotracheitis

264

1346

2.01

24.06

1.8

1.6

0.23

g/l

0.70

247

1277

Gastric ulcer

280

1456

1.96

23.96

1.7

1.5

0.24

g/l

0.23

257

1376

Acetic acid derivatives and related substances

496

1535

1.70

23.93

1.6

1.8

0.24

0.23

g/l

0.35

467

1455

Acute nephritic syndrome

194

3.98

23.92

2.3

1.4

0.25

0.23

g/l

0.60

184

Prurigo nodularis

171

4.16

23.90

1.3

1.5

0.25

0.24

g/l

0.29

166

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

629

4090

1.56

23.90

1.8

1.7

0.23

g/l

0.11

590

3879

Radiculopathy

282

1474

1.95

23.81

1.6

0.24

g/l

0.01

267

1391

Crohn disease (strict definition, require KELA, min 2 HDR)

158

663

2.47

23.74

1.8

1.7

0.24

0.23

g/l

0.22

153

619

Personality disorders, excluding more controls

494

3039

1.65

23.73

1.8

0.23

g/l

0.47

464

2901

Iron deficiency anaemia secondary to blood loss (chronic)

279

1457

1.95

23.67

1.7

1.6

0.23

g/l

0.09

264

1366

Spirochaetal infections, other/unspecified

174

762

2.36

23.66

1.9

1.6

0.22

0.24

g/l

1.50

157

723

Other or unspecified immunodeficiency

9.89

23.63

3.4

1.6

0.24

0.23

g/l

0.20

Open wound of lower leg

270

1397

1.97

23.58

2.0

1.6

0.23

0.24

g/l

0.33

255

1325

Seborrhoeic dermatitis

176

775

2.33

23.51

2.0

1.6

0.21

0.24

g/l

3.95

168

738

Injuries to the thorax

732

4926

1.50

23.49

1.7

1.6

0.24

g/l

0.33

686

4657

Polycystic ovarian syndrome, consortium definition

1490

6753

1.34

23.48

2.0

1.8

0.23

g/l

0.04

1406

6394

Crohn disease (strict definition, require KELA)

159

673

2.45

23.44

1.8

1.7

0.24

0.23

g/l

0.19

154

629

Other diseases of oesophagus

176

778

2.32

23.28

2.2

1.5

0.23

0.24

g/l

0.85

167

739

Amputation of foot

179

4.04

23.28

1.4

1.3

0.23

0.24

g/l

0.29

172

Disorder of lipoprotein metabolism, unspecified

217

1043

2.12

23.23

1.5

0.26

0.23

g/l

3.06

206

990

Other/unspecified synovitis and tenosynovitis

218

1051

2.12

23.19

2.1

1.6

0.22

0.23

g/l

1.23

210

983

Sleep disorders

422

2511

1.71

23.18

1.9

1.8

0.23

g/l

0.26

399

2385

Abnormal involuntary movements

255

1303

2.00

23.16

1.8

1.6

0.23

g/l

0.41

235

1232

Disorders of ocular muscles, binocular movement, accommodation and refraction

895

6229

1.44

23.11

1.8

0.23

g/l

0.15

834

5931

Multiple myeloma and malignant plasma cell neoplasms

332

3.11

23.08

1.8

1.5

0.24

g/l

0.09

317

Dental operations

1173

4342

1.40

23.06

1.6

0.24

0.23

g/l

0.38

1106

4098

Psoriasis vulgaris

343

1930

1.81

22.99

1.5

1.6

0.26

0.24

g/l

5.17

332

1820

Nummular dermatitis

146

598

2.51

22.98

1.4

1.6

0.24

g/l

0.09

139

573

Special screening examination for other diseases and disorders

159

676

2.41

22.96

1.7

1.5

0.25

0.23

g/l

1.86

150

647

Cytomegalovirus infection, IBD co-morbidity

224

3.71

22.95

2.2

1.6

0.25

0.23

g/l

0.84

213

Diabetes, insulin treatment (Kela reimbursement)

1864

8860

1.30

22.92

1.4

1.7

0.26

0.23

g/l

32.95

1773

8400

Other symptoms and signs involving the digestive system and abdomen

302

1636

1.88

22.90

1.8

1.6

0.22

0.23

g/l

1.45

282

1559

Benign neoplasm: Colon, unspecified

382

2207

1.75

22.88

1.6

1.5

0.24

g/l

0.19

358

2084

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

165

718

2.38

22.83

1.7

1.8

0.24

0.23

g/l

0.11

159

672

Infective dermatitis

204

965

2.16

22.82

1.6

0.23

0.24

g/l

0.14

190

912

Postprocedural disorders of nervous system

184

839

2.27

22.79

2.0

0.23

g/l

0.19

174

790

Vitreous haemorrhage

185

844

2.25

22.74

1.4

1.5

0.26

0.24

g/l

1.72

172

802

Chronic tubulo-interstitial nephritis

293

3.24

22.72

1.5

1.8

0.24

0.22

g/l

1.48

282

Adhesive capsulitis of shoulder

288

1542

1.90

22.64

1.5

1.6

0.24

g/l

0.79

274

1450

Dental pulpitis 4, only avohilmo

2164

8927

1.27

22.62

1.7

0.24

0.23

g/l

2.98

2056

8459

Diseases of middle ear and mastoid

1109

6607

1.39

22.62

1.8

0.23

g/l

0.42

1056

6295

Other bursopathies

227

1122

2.07

22.57

1.8

1.6

0.23

g/l

0.08

214

1052

Viral infections of the central nervous system

164

716

2.37

22.49

2.7

1.7

0.22

0.23

g/l

0.73

151

675

Neuralgia and neuritis, unspecified

112

409

2.84

22.34

1.6

1.7

0.23

0.24

g/l

0.04

107

376

Dermatophytosis

234

1178

2.03

22.18

2.0

1.5

0.23

0.24

g/l

2.25

225

1112

Insomnia

325

1821

1.82

22.18

1.9

1.8

0.23

g/l

0.16

304

1725

Disorders of vitreous body and globe

819

5559

1.45

22.11

1.6

0.24

g/l

0.18

765

5241

Other obstetric conditions, not elsewhere classified

744

3270

1.50

21.98

2.5

2.0

0.22

g/l

1.64

711

3105

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

730

3195

1.50

21.94

2.5

2.0

0.22

g/l

1.56

698

3036

Vascular disorders of the intestines

117

440

2.74

21.94

1.8

1.5

0.24

0.23

g/l

0.14

110

419

Corns and callosities

134

540

2.56

21.91

2.1

1.5

0.22

0.24

g/l

1.26

126

515

Hypoparathyroidism

322

3.11

21.89

2.7

1.6

0.23

g/l

0.04

307

Artrosis, including avohilmo

1596

6692

1.32

21.86

1.6

1.7

0.24

0.23

g/l

1.12

1513

6336

Early onset COPD

376

2204

1.73

21.82

1.6

0.24

g/l

0.04

352

2083

Arthropathic psoriasis

223

1112

2.06

21.76

1.6

0.25

0.24

g/l

0.85

213

1045

Diseases of external ear

579

3775

1.55

21.75

1.5

1.7

0.24

0.23

g/l

1.64

545

3578

Other follicular disorders

161

708

2.35

21.74

1.6

1.8

0.23

g/l

0.07

154

667

Disorders of vitreous body

799

5437

1.45

21.73

1.6

0.24

g/l

0.13

746

5127

Impingement syndrome of shoulder

404

2417

1.70

21.69

1.8

1.5

0.23

0.24

g/l

0.80

388

2280

Dental caries 1 and operation codes

1591

6232

1.32

21.61

1.7

1.6

0.23

g/l

0.06

1506

5889

Other psoriatic arthropathies

213

1048

2.09

21.61

1.5

1.6

0.24

g/l

0.42

204

991

Hernia

1706

8982

1.30

21.58

1.7

0.24

0.23

g/l

0.07

1598

8525

Ankylosing spondylitis

178

817

2.23

21.56

1.7

0.23

0.24

g/l

0.18

167

777

Major coronary heart disease event excluding revascularizations

997

4936

1.41

21.52

1.6

1.5

0.24

g/l

1.78

941

4661

Psoriatic arthropathies, ICD10

218

1084

2.07

21.49

1.6

0.24

g/l

0.42

209

1022

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

245

1268

1.97

21.45

1.4

1.5

0.21

0.24

g/l

4.35

229

1202

Dental caries, including avohilmo

1430

5506

1.34

21.39

1.7

1.6

0.23

g/l

0.19

1354

5197

Dental caries 1

1432

5514

1.34

21.39

1.7

1.6

0.23

g/l

0.16

1355

5205

COPD-related respiratory insufficiency

184

858

2.19

21.37

1.3

1.4

0.24

g/l

0.23

166

812

Type 2 diabetes

1821

8451

1.29

21.34

1.5

1.7

0.26

0.23

g/l

33.59

1729

8005

Persistent mood disorders

364

2129

1.74

21.32

1.8

1.7

0.23

g/l

0.08

334

2025

Epilepsy

519

3305

1.58

21.32

2.1

1.6

0.22

0.23

g/l

1.49

483

3142

Haemorrhage, not elsewhere classified

194

3.69

21.30

2.3

1.3

0.22

0.24

g/l

0.58

185

Emphysema

121

470

2.65

21.29

1.7

1.4

0.24

g/l

0.01

114

442

Varicose veins

1062

5843

1.39

21.27

1.7

1.6

0.23

0.24

g/l

1.58

1011

5517

Congenital malformations, deformations and chromosomal abnormalities

1144

8118

1.36

21.27

1.7

1.8

0.23

g/l

0.23

1093

7704

Covid-19 suspected case

421

2565

1.67

21.17

2.0

1.8

0.23

g/l

0.12

406

2438

Abnormal findings on diagnostic imaging of other body structures

240

1240

1.98

21.17

1.7

0.23

g/l

0.02

231

1173

Deviated nasal septum

541

3493

1.57

21.14

1.5

1.6

0.24

g/l

0.20

508

3322

Dental pulpitis 2

1288

4901

1.36

21.10

1.7

1.6

0.24

0.23

g/l

0.96

1221

4623

Heartburn

194

929

2.14

21.09

1.5

1.6

0.24

g/l

0.01

185

883

Retention of urine

495

2635

1.61

21.07

1.5

0.24

g/l

0.19

452

2488

Substance abuse, excluding more controls

937

5878

1.41

21.04

1.6

1.7

0.24

0.23

g/l

2.38

883

5600

Lichen planus

237

1222

1.99

21.03

1.6

0.23

0.24

g/l

0.26

226

1158

Complications of internal orthopaedic prosthetic devices, implants and grafts

349

2026

1.75

20.98

1.6

1.5

0.24

g/l

0.21

324

1895

Cirrhosis of liver, NAS

104

379

2.85

20.90

1.4

1.5

0.19

0.24

g/l

4.18

363

Other/unspecified cytomegaloviral diseases

185

3.86

20.85

2.0

1.5

0.25

0.23

g/l

0.89

178

Preparation and fitting of bite rail to mouth

286

1573

1.86

20.83

2.1

1.8

0.22

0.23

g/l

3.03

270

1487

Operations 2 for CAVS

397

2338

1.68

20.75

1.7

1.4

0.23

0.24

g/l

0.62

369

2188

Calcific aortic valvular stenosis, diagnosis (helper)

397

2338

1.68

20.75

1.7

1.4

0.23

0.24

g/l

0.62

369

2188

Abnormal serum enzyme levels

434

2640

1.64

20.71

1.8

1.5

0.24

g/l

0.59

411

2505

Speech therapy

470

2958

1.61

20.69

1.9

1.6

0.24

g/l

0.21

442

2790

Type 1 diabetes, wide definition, subgroup 1

409

2485

1.67

20.68

1.5

1.7

0.24

0.23

g/l

2.90

381

2365

Nonsuppurative otitis media

452

2422

1.64

20.67

1.9

0.22

g/l

0.23

439

2309

Calcific aortic valvular stenosis, including rheumatic fever

398

2347

1.68

20.63

1.7

1.4

0.23

0.24

g/l

0.63

370

2197

Paralytic ileus and intestinal obstruction

391

2350

1.69

20.59

1.5

1.6

0.24

g/l

0.02

366

2204

Lichen ruber planus, wide definition including periferal and oral lichen planus

372

2212

1.71

20.57

1.6

0.23

0.24

g/l

0.79

353

2086

Benign neoplasm: Colon, unspecified

382

2288

1.70

20.49

1.6

1.5

0.24

g/l

0.21

358

2157

Superficial injury of lower leg

456

2857

1.62

20.46

1.7

0.24

0.23

g/l

0.48

429

2708

Crohn's disease of large intestine

127

517

2.55

20.45

1.7

0.23

g/l

0.07

120

488

Calcific aortic valvular stenosis, operated

397

2348

1.68

20.42

1.7

1.4

0.23

0.24

g/l

0.60

369

2197

Calcific aortic valvular stenosis

397

2348

1.68

20.42

1.7

1.4

0.23

0.24

g/l

0.60

369

2197

Cerebral cysts

126

512

2.55

20.34

1.6

0.22

0.24

g/l

1.41

121

486

Dental pulpitis 1, only avohilmo

2148

8971

1.26

20.32

1.7

0.24

0.23

g/l

3.10

2040

8500

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

16.56

20.20

1.5

1.1

0.22

0.23

g/l

0.13

Injuries to the abdomen, lower back, lumbar spine and pelvis

642

4314

1.49

20.17

1.8

1.6

0.23

g/l

0.26

607

4074

Infections with a predominantly sexual mode of transmission

618

4153

1.51

20.12

2.2

1.9

0.22

0.23

g/l

2.29

581

3971

Chronic iridocyclitis

116

456

2.64

20.11

2.1

1.6

0.22

0.24

g/l

0.83

110

430

Spondylolisthesis/Spondylolysis

310

1763

1.79

20.08

1.7

1.6

0.23

0.24

g/l

1.40

293

1671

Mucosal proctocolitis

255

1370

1.90

20.00

1.5

1.8

0.23

0.24

g/l

1.13

237

1298

Other disorders of bladder

197

968

2.08

19.99

3.7

1.4

0.23

0.24

g/l

1.45

184

920

Other/unspecified enthesopathies, not elsewhere classified

160

726

2.26

19.96

1.7

1.6

0.24

g/l

0.28

155

679

Dental pulpitis 2, only avohilmo

1309

5034

1.34

19.95

1.6

0.24

0.23

g/l

0.73

1240

4744

Panic disorder

300

1696

1.80

19.89

1.6

1.9

0.23

g/l

0.38

281

1619

Angina pectoris

911

4404

1.41

19.88

1.6

1.5

0.24

g/l

2.32

862

4152

Other hammer toe(s) (acquired)

256

1287

1.89

19.86

1.7

1.4

0.23

0.24

g/l

1.50

246

1215

Unspecified fall

822

5798

1.42

19.79

1.7

1.6

0.24

0.23

g/l

1.74

773

5501

Acute pharyngitis

273

1491

1.85

19.76

1.8

0.23

g/l

0.58

258

1421

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

180

861

2.15

19.72

1.6

1.7

0.24

g/l

0.33

167

816

Other local infections of skin and subcutaneous tissue

190

928

2.10

19.67

2.1

1.6

0.24

0.23

g/l

0.17

175

881

Vitamin deficiency, wide

108

415

2.70

19.60

2.2

1.6

0.21

0.23

g/l

1.41

101

394

Vitamin deficiency

108

415

2.70

19.60

2.2

1.6

0.21

0.23

g/l

1.41

101

394

Problems related to lifestyle

203

1017

2.04

19.57

1.9

1.7

0.23

0.24

g/l

0.32

196

965

Arthropathy in hypersensitivity reactions classified elsewhere

21.39

19.49

1.5

1.1

0.23

0.25

g/l

0.25

Dental caries 3 and operation codes

1667

6671

1.29

19.38

1.7

1.6

0.23

g/l

0.34

1580

6309

Other/unspecified enthesopathies of lower limb, excluding foot

148

660

2.31

19.34

1.5

1.7

0.24

g/l

0.06

141

624

Sub-endpoint used in defining T1D endpoints

514

3296

1.55

19.28

1.6

1.7

0.24

0.23

g/l

2.65

481

3134

Other and unspecified tonsillitis

617

3531

1.50

19.26

1.7

1.8

0.24

0.23

g/l

2.92

585

3368

Tongue abnormality

128

538

2.46

19.24

2.1

1.6

0.23

g/l

0.51

120

511

Pain associated with micturition

222

1158

1.96

19.09

2.1

1.6

0.22

0.23

g/l

0.86

206

1098

Haemorrhoids and perianal venous thrombosis

450

2856

1.59

19.02

1.5

0.23

0.24

g/l

0.77

434

2675

Suppurative and unspecified otitis media

697

4286

1.46

19.01

1.9

0.23

g/l

0.05

661

4094

Type 1 diabetes, wide definition

421

2632

1.62

19.00

1.5

1.8

0.24

0.23

g/l

3.20

392

2503

574

3611

1.51

18.99

1.7

1.5

0.23

0.24

g/l

2.31

532

3393

Other noninfective disorders of lymphatic vessels and lymph nodes

310

2.97

18.94

1.7

1.6

0.24

0.23

g/l

0.24

290

Other and unspecified local infections of skin and subcutaneous tissue

179

869

2.11

18.87

2.1

1.6

0.24

0.23

g/l

0.43

164

825

Diabetic retinopathy

546

2256

1.55

18.86

1.4

1.5

0.26

0.25

g/l

1.78

519

2141

Major coronary heart disease event

1084

5371

1.36

18.83

1.6

1.5

0.24

g/l

1.43

1027

5076

Meningitis

114

459

2.58

18.82

2.8

1.6

0.22

0.24

g/l

1.17

104

435

Pneumonia derived septicemia

284

3.06

18.81

3.2

1.4

0.23

0.24

g/l

0.42

270

Other epidermal thickening

339

2.85

18.71

2.1

1.5

0.24

g/l

0.13

321

Post-traumatic stress disorder

186

922

2.07

18.57

1.5

2.0

0.24

0.22

g/l

1.39

172

877

Generalized anxiety disorder

304

1761

1.76

18.55

1.7

1.8

0.23

g/l

0.07

291

1682

Cervicocranial syndrome

199

1012

2.01

18.42

1.5

1.7

0.23

0.24

g/l

0.79

190

959

Acute lymphadenitis

137

605

2.34

18.40

2.4

1.6

0.22

0.23

g/l

0.85

132

567

Cryoglobulinemia

19.96

18.37

3.2

1.4

0.23

0.26

g/l

0.47

Persons with potential health hazards related to communicable diseases

757

5340

1.42

18.31

2.1

1.8

0.24

0.23

g/l

1.53

723

5108

Diabetic retinopathy, strict definition

307

1565

1.76

18.30

1.3

1.5

0.26

0.25

g/l

1.29

292

1485

Viral and other specified intestinal infections

388

2348

1.64

18.18

2.0

1.8

0.22

0.23

g/l

0.30

364

2254

Fracture of rib(s), sternum and thoracic spine

449

2882

1.58

18.18

1.7

1.6

0.24

g/l

0.28

423

2723

Acute pancreatitis

319

1883

1.72

18.15

1.5

1.6

0.25

0.23

g/l

1.87

308

1780

Acute suppurative otitis media

518

3199

1.53

18.15

1.9

0.23

g/l

0.08

494

3063

Acute laryngitis and tracheitis

229

1208

1.90

18.03

1.9

1.8

0.23

g/l

0.55

217

1157

Lichen planus, including avohilmo

315

1859

1.73

18.00

1.6

0.23

0.24

g/l

0.52

298

1755

Non-follicular lymphoma

160

758

2.16

17.99

1.7

1.5

0.22

0.24

g/l

1.31

145

722

Cholelithiasis, broad definition with cholecystitis

1538

8274

1.28

17.96

1.7

0.24

0.23

g/l

6.31

1449

7828

Cluster headache, wide

325

2.84

17.87

1.8

1.6

0.23

0.24

g/l

0.72

307

Endometriosis of pelvic peritoneum

343

2049

1.68

17.79

1.7

1.8

0.23

g/l

0.62

323

1931

Nonorganic sleeping disorders

362

2222

1.66

17.79

1.9

1.8

0.23

g/l

0.03

342

2117

Disorders of oesophagus in diseases classified elsewhere

176

3.63

17.66

2.3

1.3

0.23

0.24

g/l

0.05

168

Seborrhoeic keratosis

323

1929

1.70

17.59

2.1

1.5

0.23

0.24

g/l

0.92

295

1823

Melanocytic naevi

519

3471

1.51

17.46

2.2

1.7

0.22

0.23

g/l

2.33

490

3314

Diabetes medication

1900

9304

1.25

17.42

1.4

1.8

0.26

0.23

g/l

36.85

1804

8823

Neuromuscular dysfunction of bladder

158

755

2.14

17.38

1.8

1.5

0.23

0.24

g/l

0.51

143

717

Extrapyramidal and movement disorders

570

3886

1.48

17.37

1.6

0.23

0.24

g/l

1.06

536

3655

Tonsillectomy and adenotomy

1149

6081

1.33

17.33

1.8

1.9

0.22

0.23

g/l

1.43

1096

5805

Other disorders of pigmentation

342

2.76

17.30

1.6

1.5

0.23

0.24

g/l

0.41

322

Non-follicular lymphoma, hilmo, excluding all cancers

160

770

2.13

17.29

1.7

1.5

0.22

0.23

g/l

0.86

145

728

Other acute skin changes due to ultraviolet radiation

293

2.92

17.20

2.2

1.5

0.22

0.24

g/l

1.19

282

Cardiodefibrillation

515

3442

1.51

17.18

1.7

1.5

0.24

g/l

0.09

491

3235

Menorrhagia

721

2800

1.44

17.11

2.0

1.7

0.23

g/l

0.61

676

2640

Disorders of vestibular function (Vertigo)

751

5363

1.40

17.06

1.7

1.6

0.23

g/l

0.05

719

5052

Other and unspecified diseases of blood and blood-forming organs

215

3.29

17.06

2.3

1.6

0.24

0.23

g/l

0.23

206

Lesion of ulnar nerve

240

1332

1.84

17.01

1.7

1.6

0.23

0.24

g/l

0.43

230

1265

Diseases of peritoneum

183

932

2.01

16.94

1.7

1.6

0.24

g/l

0.58

176

883

Aortic valve malfunction, age under 60 years

177

893

2.03

16.87

2.1

1.6

0.23

0.24

g/l

0.43

161

853

Visual field defects

148

699

2.17

16.82

2.0

1.6

0.23

0.24

g/l

0.55

139

661

Other extrapyramidal and movement disorders in other diseases

368

2302

1.62

16.76

1.7

1.6

0.23

0.24

g/l

1.51

344

2171

Other disorders of ear

1613

8559

1.26

16.67

1.7

1.6

0.23

g/l

0.84

1523

8116

Calcinosis cutis

17.94

16.54

2.1

1.4

0.21

0.25

g/l

0.86

Cluster headache, strict

312

2.80

16.38

1.9

1.6

0.23

0.24

g/l

0.75

295

Inflammatory disease of uterus

300

1798

1.70

16.30

2.0

1.9

0.23

g/l

0.25

275

1709

Other disorders of eyelid

658

4501

1.43

16.29

1.6

1.5

0.23

0.24

g/l

0.14

623

4234

Myocardial infarction, strict

672

3459

1.43

16.28

1.6

1.5

0.24

0.23

g/l

2.14

635

3251

Acne

215

1170

1.88

16.28

2.1

1.9

0.21

0.22

g/l

0.80

199

1117

Chronic pancreatitis

204

1092

1.91

16.27

1.4

1.5

0.24

g/l

0.01

191

1036

Dental caries 1, only avohilmo

1435

5748

1.28

16.25

1.7

0.23

g/l

0.07

1356

5424

Need for other prophylactic measures

115

498

2.39

16.24

1.9

1.5

0.25

0.24

g/l

0.49

108

472

Synovial cyst of popliteal space [Baker]

127

573

2.27

16.18

1.5

1.6

0.24

g/l

0.07

121

538

Arterial embolism and thrombosis

383

2.57

16.09

1.4

0.25

0.24

g/l

0.54

364

KRA_PSY_EATING, excluding more controls

180

926

1.98

16.05

1.9

0.21

0.22

g/l

0.19

173

884

FESS (DNB20)

239

1352

1.80

15.99

1.5

1.7

0.23

0.24

g/l

0.42

231

1280

Hyperkinetic disorders, excluding more controls

196

1012

1.92

15.98

1.7

1.9

0.22

g/l

0.35

185

971

Otitis externa

388

2487

1.58

15.96

1.7

0.24

0.23

g/l

0.81

368

2354

Cholelithiasis

1467

8156

1.27

15.93

1.7

0.24

0.23

g/l

6.03

1380

7718

Acute pancreatitis (for exclusion)

319

1953

1.66

15.87

1.5

0.25

0.24

g/l

1.31

308

1848

Otitis externa, unspecified

208

1131

1.88

15.85

1.6

1.7

0.24

0.23

g/l

0.82

197

1072

Elevated blood glucose level

144

689

2.14

15.85

1.3

1.5

0.25

0.24

g/l

0.79

136

655

Fissure and fistula of anal and rectal regions

395

2545

1.57

15.82

1.7

1.6

0.24

g/l

0.27

372

2402

Disorders of refraction and accommodation

488

3279

1.50

15.80

1.9

1.8

0.23

g/l

0.18

455

3124

Other medical care

605

4147

1.44

15.76

1.4

1.6

0.24

0.23

g/l

0.35

578

3907

Hydronephrosis

170

865

2.00

15.75

1.4

1.6

0.25

0.23

g/l

2.09

165

817

Dental caries 2

1452

9066

1.27

15.75

1.9

1.8

0.23

g/l

2.75

1382

8607

Injuries to the head

2011

10749

1.22

15.72

1.7

0.23

g/l

0.54

1909

10195

Trigeminal neuralgia

118

524

2.32

15.70

1.7

1.6

0.23

g/l

0.08

112

496

Scoliosis

168

854

2.01

15.68

1.7

1.9

0.23

g/l

0.07

157

814

Decubitus ulcer and pressure area

353

2.62

15.66

1.6

1.4

0.25

0.24

g/l

0.45

339

Atypical facial pain

109

469

2.40

15.64

1.7

0.23

g/l

0.35

101

447

Dental caries 3

1486

6010

1.27

15.53

1.7

0.23

g/l

0.68

1411

5679

Anti-inflammatory and antirheumatic products, non-steroids

511

1710

1.51

15.49

1.5

1.8

0.23

g/l

0.85

488

1625

Melanocytic naevi

519

3561

1.48

15.43

2.2

1.7

0.22

0.23

g/l

2.76

490

3389

Mononeuritis multiplex

11.82

15.35

1.9

1.6

0.21

0.25

g/l

0.75

Ethmoidectomy

245

1413

1.77

15.34

1.5

1.7

0.23

0.24

g/l

0.61

237

1336

Benign neoplasm: Ascending colon

201

1092

1.88

15.34

1.4

1.5

0.25

0.24

g/l

0.99

190

1028

Benign neoplasm: Sigmoid colon

273

1621

1.71

15.31

1.5

0.23

0.24

g/l

0.35

262

1531

Injuries to the hip and thigh

700

4634

1.39

15.20

1.7

1.6

0.24

0.23

g/l

0.37

666

4370

Left ventricular outflow tract obstruction (LVOTO), broad definition

189

1011

1.91

15.20

2.2

1.5

0.24

g/l

0.04

171

966

Intestinal malabsorption

414

2.48

15.17

1.5

1.7

0.22

0.24

g/l

1.59

393

Propionic acid derivatives

509

1710

1.51

15.16

1.6

1.8

0.23

g/l

0.74

487

1625

Other female pelvic inflammatory diseases

318

1972

1.64

15.14

1.9

1.8

0.22

0.23

g/l

0.80

294

1867

Suppurative and necrotic conditions of lower respiratory tract

414

2.46

15.11

2.1

1.3

0.24

g/l

0.11

395

Fracture of lumbar spine and pelvis

317

1961

1.64

15.05

1.9

1.5

0.23

0.24

g/l

0.16

303

1829

Dental caries 2 and operation codes

1422

9009

1.26

15.01

1.9

1.8

0.22

0.23

g/l

2.64

1354

8550

Erosion of teeth, including avohilmo

361

2231

1.58

14.92

1.8

0.23

g/l

0.25

349

2123

Lateral epicondylitis

227

1290

1.79

14.92

1.6

0.24

g/l

0.71

219

1217

Procreative management

606

3620

1.43

14.83

1.8

0.23

g/l

0.17

561

3463

Invasive ventilation

130

615

2.17

14.80

1.6

1.4

0.24

g/l

0.47

116

584

Other diseases of pancreas

129

609

2.17

14.76

1.7

1.5

0.22

0.24

g/l

1.82

120

580

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

682

4942

1.39

14.76

1.9

1.8

0.24

0.23

g/l

1.37

656

4721

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

337

2135

1.61

14.69

2.1

2.0

0.22

0.23

g/l

0.43

324

2032

Other and unspecified nerve root and plexus disorders, also in other diseases

314

1956

1.63

14.63

1.6

1.7

0.24

g/l

0.29

291

1858

Aortic aneurysm

286

1709

1.66

14.54

1.5

1.4

0.23

0.24

g/l

0.42

269

1615

Ankylosing spondylitis, ICD10

173

913

1.94

14.53

1.6

1.7

0.23

0.24

g/l

0.15

162

866

Cluster headache, wide,, including avohilmo

115

524

2.27

14.47

1.8

1.7

0.23

0.24

g/l

0.24

110

492

Benign neoplasm: Ascending colon

201

1114

1.84

14.42

1.4

1.5

0.25

0.24

g/l

0.65

190

1052

Bruxism

201

3.17

14.33

2.3

1.6

0.21

0.24

g/l

1.81

191

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

389

2.48

14.30

2.0

1.5

0.23

g/l

0.01

371

Diabetic neuropathy

186

1005

1.88

14.26

1.3

1.4

0.26

0.25

g/l

0.12

177

951

Benign neoplasm: Stomach

166

872

1.95

14.14

1.5

1.6

0.23

0.24

g/l

0.10

155

822

Ganglion

348

2238

1.57

14.13

1.4

1.7

0.24

0.23

g/l

0.81

331

2125

Chondrocostal junction syndrome [Tietze]

337

2.59

14.13

1.6

0.24

g/l

0.05

322

Disorders of optic nerve and visual pathways

186

1015

1.87

14.11

2.0

1.7

0.23

g/l

0.00

177

955

Benign neoplasm of other and unspecified endocrine glands

222

1277

1.77

14.08

1.5

1.6

0.25

0.24

g/l

0.92

202

1204

Benign neoplasm of other and unspecified endocrine glands

222

1278

1.77

14.04

1.5

1.6

0.25

0.23

g/l

1.51

202

1204

Restless leg syndrome

213

1212

1.79

14.04

1.7

1.6

0.23

0.24

g/l

0.64

202

1147

Cluster headache, strict, including avohilmo

110

499

2.28

14.01

1.8

1.7

0.23

g/l

0.17

105

467

Noninflammatory disorders of female genital tract

882

3323

1.35

14.01

2.0

1.8

0.22

0.23

g/l

0.56

840

3147

Dental operations, only avohilmo

1210

4847

1.29

13.99

1.6

0.24

0.23

g/l

0.17

1147

4574

Other or unspecified ileus, impaction or obstruction

259

1553

1.69

13.97

1.3

1.5

0.24

g/l

0.19

245

1457

Injuries to the neck

400

2660

1.52

13.97

1.6

1.8

0.24

0.23

g/l

0.39

384

2532

Anogenital herpesviral [herpes simplex] infection

140

698

2.06

13.94

2.4

2.0

0.21

0.23

g/l

1.34

132

657

Diseases of inner ear

854

6339

1.33

13.84

1.6

0.23

g/l

0.21

815

5980

Unspecified/other endometriosis

201

1131

1.82

13.79

1.6

1.9

0.24

0.22

g/l

1.95

184

1066

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

406

2717

1.51

13.77

1.3

1.7

0.27

0.23

g/l

15.96

388

2579

Amenorrhoea

158

827

1.96

13.66

2.3

2.0

0.22

g/l

0.20

151

782

Intracranial injury

932

6921

1.31

13.63

1.8

1.7

0.23

g/l

0.51

878

6565

Substance abuse

937

6893

1.31

13.53

1.6

1.7

0.24

0.23

g/l

2.36

883

6577

Benign neoplasm: Stomach

166

887

1.91

13.45

1.5

1.6

0.23

0.24

g/l

0.26

155

844

Corneal ulcer

307

1943

1.60

13.43

1.8

1.7

0.24

g/l

0.02

290

1845

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

481

3342

1.45

13.41

1.7

1.9

0.23

g/l

0.12

440

3186

Benign neoplasm: Transverse colon

156

818

1.95

13.38

1.6

1.5

0.25

0.23

g/l

1.60

148

769

Injuries to the wrist and hand

1789

10714

1.22

13.36

1.7

0.23

g/l

0.19

1692

10171

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

293

1839

1.62

13.30

1.5

1.7

0.22

0.23

g/l

1.65

274

1744

Nasal polyp

297

1869

1.61

13.29

1.5

1.6

0.23

0.24

g/l

0.16

284

1766

Chondropathies

279

1732

1.64

13.27

1.8

0.24

0.23

g/l

0.16

262

1642

COPD, hospital admissions 1, only main diagnosis

462

2707

1.47

13.26

1.5

0.24

g/l

0.00

436

2549

Other disorders of conjunctiva

221

1292

1.74

13.23

1.8

1.6

0.23

0.24

g/l

0.34

208

1219

Oesophageal varices

300

2.62

13.20

1.4

1.6

0.20

0.24

g/l

2.42

284

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

551

3897

1.41

13.12

1.9

0.23

g/l

0.05

521

3725

Carrier of infectious disease

239

2.86

13.11

2.3

1.6

0.25

0.23

g/l

0.43

227

Phobic anxiety disorders

249

1506

1.68

13.10

1.6

1.8

0.23

g/l

0.14

242

1439

Impetigo

100

449

2.30

13.08

2.2

1.6

0.22

0.23

g/l

0.80

426

Benign neoplasm: Sigmoid colon

273

1692

1.64

13.05

1.5

0.23

0.24

g/l

0.65

262

1598

Other sleep disorders

182

1010

1.83

13.04

1.9

1.6

0.23

g/l

0.30

172

956

Mental and behavioural disorders due to psychoactive substance use

965

7072

1.30

13.02

1.6

1.7

0.24

0.23

g/l

1.98

910

6744

Pneumococcal septicemia

297

2.63

13.00

3.4

1.4

0.23

0.24

g/l

0.06

284

Viral meningitis

357

2.47

12.99

3.1

1.6

0.22

0.24

g/l

0.82

335

Ulcerative colitis (strict definition, require KELA)

300

1905

1.60

12.98

1.5

1.7

0.22

0.23

g/l

1.70

281

1806

Lung diseases due to external agents

188

1054

1.81

12.97

1.7

1.4

0.23

0.24

g/l

0.19

180

996

Rapidly progressive nephritic syndrome

13.92

12.96

2.0

1.4

0.28

0.23

g/l

0.74

Insulin, fast-acting (human)

258

1581

1.66

12.92

1.5

1.8

0.24

0.23

g/l

1.08

243

1500

Retinal vascular occlusion

169

920

1.87

12.88

1.3

1.5

0.24

g/l

0.31

161

860

Otitis media, unspecified

217

1170

1.74

12.77

1.7

1.8

0.22

g/l

0.36

206

1117

Retinal detachments and breaks

508

3599

1.43

12.76

1.5

1.6

0.24

g/l

0.01

485

3387

Type 2 diabetes, definitions combined

1635

8010

1.22

12.69

1.4

1.7

0.26

0.23

g/l

32.58

1557

7583

Benign neoplasm: Transverse colon

156

833

1.91

12.69

1.6

1.5

0.25

0.24

g/l

0.84

148

789

Listeriosis

6.58

12.66

2.6

1.1

0.20

0.26

g/l

2.68

Hypopituitarism

134

681

2.02

12.65

1.8

1.5

0.23

0.24

g/l

0.14

128

650

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

896

6054

1.31

12.62

2.0

1.9

0.23

g/l

0.84

855

5737

Other disorders of nervous system

116

560

2.12

12.61

1.5

0.23

0.24

g/l

0.37

106

532

Open wound of ankle and foot

173

956

1.84

12.61

1.8

1.6

0.24

g/l

0.02

161

904

Degeneration of macula and posterior pole

613

3689

1.38

12.54

1.8

1.5

0.23

0.24

g/l

0.77

573

3449

Childhood allergy (age < 16)

295

1539

1.60

12.53

1.8

2.0

0.22

g/l

0.05

281

1480

Pyothorax

320

2.52

12.51

2.3

1.3

0.24

g/l

0.06

307

Thoracic aortic aneurysm

188

1067

1.79

12.50

1.4

0.23

0.24

g/l

0.30

175

1009

Thyrotoxicosis

428

2953

1.47

12.50

1.7

0.23

g/l

0.36

398

2784

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

139

720

1.98

12.43

1.9

1.7

0.25

0.23

g/l

1.62

129

685

Nonischemic cardiomyopathy

426

2.29

12.42

1.6

1.5

0.23

0.24

g/l

0.49

407

Thyroiditis

147

777

1.94

12.42

1.9

1.8

0.22

0.23

g/l

0.68

140

732

Retinal vascular disorders

169

931

1.84

12.41

1.3

1.5

0.24

g/l

0.33

161

870

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

319

2077

1.56

12.38

1.5

1.7

0.22

0.23

g/l

1.65

300

1973

Cholecystectomy

1179

8344

1.26

12.33

1.7

0.25

0.23

g/l

6.11

1112

7893

Intestinal stricture

441

3066

1.45

12.32

1.6

0.23

0.24

g/l

0.12

410

2890

Actinic keratosis

480

3213

1.43

12.30

1.6

1.5

0.22

0.24

g/l

2.37

446

3009

Speech disturbances, not elsewhere classified

132

674

2.00

12.26

1.8

1.5

0.24

g/l

0.06

122

640

Personality disorders

494

3513

1.42

12.22

1.8

0.23

g/l

0.28

464

3364

conjunctival haemorrhage

119

589

2.07

12.10

1.9

1.5

0.23

0.24

g/l

0.84

111

565

Type 2 diabetes, strict (exclude DM1)

1637

8065

1.22

12.10

1.4

1.7

0.26

0.23

g/l

32.30

1559

7638

Abnormal blood-pressure reading, without diagnosis

362

2.38

12.08

1.9

1.6

0.24

0.23

g/l

0.62

343

Delirium, not induced by alcohol and other psychoactive substances

147

782

1.91

12.00

2.0

1.4

0.22

0.24

g/l

1.38

138

737

Acne vulgaris

162

894

1.85

11.91

1.9

0.22

g/l

0.07

152

853

Dislocation, sprain and strain of joints and ligaments at neck level

279

1780

1.59

11.90

1.6

1.9

0.24

0.23

g/l

1.27

269

1690

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

296

1853

1.57

11.81

1.6

1.7

0.23

g/l

0.52

288

1758

Skin changes due to chronic exposure to nonionizing radiation

495

3347

1.41

11.76

1.6

1.5

0.23

0.24

g/l

2.28

456

3136

Congenital malformations of the urinary system

117

583

2.06

11.74

1.7

1.6

0.25

0.23

g/l

0.93

117

551

Myeloproliferative diseases

133

692

1.96

11.74

1.5

0.22

0.24

g/l

1.10

121

655

Unspecific neurodegenerative disorder

219

2461

0.61

11.71

1.4

0.23

g/l

0.54

201

2305

Disorders of continuity of bone

169

950

1.81

11.70

2.1

1.6

0.23

g/l

0.45

161

893

Supplementary factors related to causes of morbidity and mortality classified elsewhere

496

3557

1.41

11.69

1.8

1.7

0.24

0.23

g/l

0.40

473

3367

Other disorders of the musculoskeletal system and connective tissue

233

1431

1.65

11.64

1.6

0.24

g/l

0.17

220

1351

Appendectomy

1162

9018

1.25

11.62

1.7

0.24

0.23

g/l

0.79

1102

8562

Viral pneumonia (known virus, not influenza)

203

2.89

11.62

1.7

1.4

0.23

0.24

g/l

0.11

193

Superficial injury of head

357

2412

1.50

11.60

1.6

1.7

0.23

g/l

0.01

344

2276

Other noninflammatory disorders of vagina

151

823

1.87

11.59

2.6

1.8

0.22

0.23

g/l

0.29

142

770

Autoimmune hyperthyroidism

413

2.25

11.55

1.6

1.2

0.22

0.25

g/l

1.70

391

Dental caries 3, only avohilmo

1486

6225

1.23

11.54

1.7

0.23

g/l

0.36

1411

5880

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

487

3492

1.41

11.50

1.8

0.23

g/l

0.16

457

3325

Benign paroxysmal vertigo

442

3120

1.43

11.44

1.7

1.6

0.23

0.24

g/l

0.12

424

2925

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

366

2270

1.48

11.30

1.9

0.22

g/l

0.53

347

2175

Endometriosis of rectovaginal septum and vagina

152

838

1.85

11.26

1.4

1.8

0.23

g/l

0.04

143

785

Demyelinating diseases of the central nervous system

173

993

1.78

11.21

1.8

1.9

0.23

g/l

0.25

166

934

Opening and dilatation of root channel of tooth

123

635

1.98

11.17

2.2

1.7

0.23

0.24

g/l

0.48

115

597

Parodontitis

1509

9215

1.21

11.13

1.8

1.6

0.24

0.23

g/l

1.33

1426

8733

Parodontitis or operation codes

1510

9218

1.21

11.09

1.8

1.6

0.24

0.23

g/l

1.31

1427

8736

Lesion of lateral popliteal nerve

402

2.25

11.07

1.6

1.5

0.24

g/l

0.28

379

Chronic periodontitis, including avohilmo

1502

9210

1.21

11.05

1.8

1.6

0.24

0.23

g/l

1.15

1419

8731

Transport accidents

771

5270

1.31

11.03

1.8

1.7

0.24

0.23

g/l

2.24

739

5033

Injuries to the shoulder and upper arm

1355

9339

1.22

11.00

1.7

1.6

0.23

g/l

0.24

1282

8855

Pneumonia due to Streptococcus pneumoniae

315

2.41

10.97

1.7

1.4

0.23

0.24

g/l

0.23

301

Other contact dermatitis

135

723

1.90

10.93

1.8

0.23

g/l

0.16

127

682

Olecranon bursitis

423

2.20

10.93

1.9

1.4

0.23

0.25

g/l

0.60

397

Cyst of kidney

106

523

2.07

10.92

1.4

1.5

0.26

0.24

g/l

1.18

100

500

Fibroblastic disorders

317

2119

1.51

10.88

1.6

1.5

0.23

g/l

0.21

300

1990

Substance use, excluding alcohol

325

2187

1.50

10.85

1.8

0.24

0.23

g/l

0.49

310

2089

Gonarthrosis,primary

1415

7329

1.22

10.84

1.6

0.24

g/l

2.24

1335

6932

Other ulcerative colitis

110

554

2.03

10.74

1.5

1.6

0.22

0.24

g/l

1.68

525

Exclusions for E4_PCOS_CONSORTIUM

1381

7124

1.22

10.70

1.7

1.8

0.23

g/l

0.61

1317

6762

Non-allergic asthma

145

801

1.84

10.65

1.9

1.6

0.23

g/l

0.18

140

759

Extreme obesity with alveolar hypoventilation

346

2.33

10.59

1.3

1.6

0.25

0.24

g/l

0.93

329

Disorders of adult personality and behaviour

508

3726

1.38

10.51

1.8

0.23

g/l

0.19

475

3569

Degenerative macular diseases

167

966

1.75

10.48

2.2

1.5

0.23

0.24

g/l

0.76

157

903

Other specified/unspecified bacterial intestinal infections

112

574

2.00

10.41

1.8

1.5

0.22

0.24

g/l

0.87

102

543

Alzheimer disease, including avohilmo

166

2026

0.59

10.40

1.3

1.4

0.23

g/l

0.28

151

1886

Ascites

109

553

2.01

10.40

2.2

1.5

0.22

0.24

g/l

1.25

100

530

Other hearing loss

368

2513

1.45

10.37

1.7

1.5

0.23

0.24

g/l

0.44

348

2363

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

469

4202

0.72

10.36

1.5

1.8

0.24

0.23

g/l

0.53

434

3975

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

469

4202

0.72

10.36

1.5

1.8

0.24

0.23

g/l

0.53

434

3975

Injuries to unspecified part of trunk, limb or body region

161

926

1.77

10.35

2.1

1.5

0.24

0.23

g/l

0.35

150

878

Type of accident

452

3261

1.40

10.35

1.9

1.7

0.23

g/l

0.21

431

3089

Myeloproliferative diseases (CML excluded)

119

624

1.95

10.33

1.5

0.22

0.24

g/l

1.37

108

594

Other and unspecified disorders of vitreous body

602

4517

1.34

10.33

1.6

0.23

0.24

g/l

1.19

564

4265

D07AA Corticosteroids, weak (group I)

280

1847

1.53

10.29

1.6

1.9

0.24

0.23

g/l

1.24

263

1763

Dental caries 2, only avohilmo

1378

9007

1.21

10.29

1.9

1.8

0.22

0.23

g/l

3.46

1314

8546

Cardiac murmurs and other cardiac sounds

154

865

1.79

10.28

1.8

1.7

0.22

g/l

0.01

146

827

Mouth breathing

644

4905

1.32

10.26

1.7

1.6

0.24

g/l

0.92

613

4669

Colonic or urogenital fistula

426

3049

1.41

10.24

1.9

1.6

0.24

g/l

0.15

400

2893

Achilles tendinitis

164

951

1.75

10.23

1.8

1.7

0.23

0.24

g/l

0.43

156

905

Trigger finger

212

1315

1.63

10.22

1.6

0.23

g/l

0.07

206

1240

Plantar fascial fibromatosis

155

887

1.78

10.14

1.9

1.7

0.23

g/l

0.39

145

829

Pregnancy hypertension

799

5652

1.28

10.10

2.0

1.9

0.23

g/l

0.58

760

5361

Parodontitis and operation codes

1411

9126

1.21

10.09

1.8

1.6

0.24

g/l

0.67

1334

8653

Vulvovaginal ulceration/inflammation in other diseases

125

673

1.90

10.08

1.6

2.2

0.22

g/l

0.56

120

633

Cerebral aneurysm, nonruptured

141

787

1.83

10.07

2.0

1.7

0.24

0.23

g/l

0.02

135

739

Vitamin B12 deficiency anaemia

149

847

1.78

9.95

1.8

1.5

0.22

0.24

g/l

1.63

139

797

Barrett oesophagus

375

2.22

9.92

1.6

1.4

0.24

0.25

g/l

0.36

359

887

6483

1.26

9.91

1.6

1.7

0.24

g/l

0.87

830

6178

Endometriosis ASRM stages 1,2

347

2413

1.46

9.90

1.7

1.9

0.23

g/l

0.62

326

2289

Conductive and sensorineural hearing loss

1231

7002

1.22

9.89

1.6

0.23

0.24

g/l

2.12

1160

6626

Other and unspecified vaccines and biological substances

4.29

9.89

1.3

1.6

0.24

g/l

0.10

Specific personality disorders

417

2994

1.41

9.88

1.7

1.8

0.23

g/l

0.25

390

2861

Familial hypercholesterolemia

204

1264

1.63

9.88

1.9

1.5

0.25

0.23

g/l

2.45

194

1196

Melanocytic naevi of trunk

198

1220

1.65

9.87

2.1

1.7

0.23

g/l

0.35

190

1145

Thyrotoxicosis, other and/or unspecified

322

2207

1.48

9.86

1.7

0.23

g/l

0.05

299

2092

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

312

2.34

9.86

1.8

1.6

0.23

g/l

0.13

299

Alcohol use disorder, Swedish definition

835

6133

1.27

9.84

1.6

0.24

g/l

1.00

781

5841

Acute gastritis

119

635

1.91

9.80

1.8

1.5

0.24

g/l

0.22

114

605

Malignant neoplasm of breast

524

5048

0.74

9.79

1.4

1.7

0.24

0.23

g/l

1.05

489

4765

Disorders of orbit

404

2.16

9.76

1.7

1.6

0.24

0.23

g/l

0.18

383

Other keratitis

183

1109

1.68

9.74

2.0

1.7

0.24

0.23

g/l

0.80

172

1044

Lymphoid leukaemia

424

2.12

9.72

1.9

1.5

0.25

0.23

g/l

1.19

403

Other nonautoimmune haemolytic anaemias

10.59

9.71

2.0

1.4

0.19

0.25

g/l

1.69

N06DA Anticholinesterases

153

2092

0.59

9.69

1.3

1.4

0.23

g/l

0.16

139

1952

Use of anticholinesterases

153

2092

0.59

9.69

1.3

1.4

0.23

g/l

0.16

139

1952

Postmenopausal osteoporosis with pathological fracture

445

2.09

9.67

2.0

1.5

0.22

0.23

g/l

0.23

418

Later onset COPD

321

1720

1.48

9.66

1.3

1.4

0.24

0.23

g/l

0.43

305

1612

Injury of unspecified body region

125

682

1.87

9.64

2.1

1.5

0.24

g/l

0.01

115

647

Aneurysms, operations, SAH

243

1579

1.56

9.64

1.9

1.6

0.24

g/l

0.14

230

1493

Secondary and unspecified malignant neoplasm of lymph nodes

126

689

1.86

9.63

1.5

0.24

g/l

0.14

118

657

Infarction of spleen

5.59

9.58

1.6

1.3

0.22

0.23

g/l

0.34

Cholecystitis

194

1197

1.64

9.57

1.4

1.5

0.24

g/l

0.53

186

1129

Left bundle-branch block

473

2.04

9.56

1.6

1.5

0.23

0.24

g/l

0.59

446

Sequelae of injuries, of poisoning and of other consequences of external causes

376

2670

1.42

9.51

1.6

1.7

0.24

g/l

0.88

358

2536

Dysplasia of cervi uteri

449

2527

1.39

9.49

2.5

1.8

0.22

0.23

g/l

1.53

419

2392

Melanocytic naevi of trunk

198

1233

1.63

9.48

2.1

1.7

0.23

g/l

0.61

190

1163

Spontaneous rupture of synovium and tendon

119

643

1.88

9.44

1.8

1.5

0.24

g/l

0.10

113

601

Lung cancer and mesothelioma

195

1027

1.64

9.42

1.4

0.24

g/l

0.43

183

964

Ulcerative colitis (strict definition, all Crohn cases excluded)

242

1582

1.55

9.37

1.5

1.7

0.22

0.24

g/l

2.45

229

1497

Bipolar affective disorders

320

2218

1.46

9.27

2.0

1.8

0.23

g/l

0.43

306

2121

Other (not insulin) diabetes medications

1629

8315

1.19

9.25

1.4

1.7

0.26

0.23

g/l

38.45

1545

7878

Ulcerative enterocolitis

296

2.34

9.24

1.8

1.6

0.22

0.24

g/l

0.72

283

Fracture of foot, except ankle

395

2846

1.40

9.20

1.9

1.6

0.23

g/l

0.07

372

2713

Use of pramipexole

322

2238

1.45

9.20

2.0

1.6

0.24

g/l

0.01

309

2105

Oral lichen ruber planus, including avohilmo

107

565

1.94

9.20

1.8

1.7

0.22

0.24

g/l

0.89

102

532

Type 2 diabetes, definitions combined, including avohilmo

1613

8081

1.19

9.19

1.4

1.7

0.26

0.23

g/l

31.31

1535

7656

Panniculitis affecting regions of neck and back

309

2.29

9.18

1.7

1.6

0.23

0.24

g/l

0.31

289

Malignant neoplasm of breast, HER2-negative

508

4956

0.75

9.18

1.4

1.7

0.24

0.23

g/l

0.98

475

4675

Adenomyosis (Endometriosis of uterus)

234

1528

1.55

9.14

1.8

1.7

0.23

g/l

0.08

224

1431

Benign neoplasm: Small intestine

323

2.26

9.13

1.4

1.6

0.24

0.23

g/l

0.38

310

Intestinal adhesions without obstruction

121

665

1.85

9.12

1.7

1.5

0.23

0.24

g/l

0.59

108

628

Pneumothorax

510

1.98

9.09

1.7

1.4

0.24

g/l

0.01

488

Hallux rigidus

177

1082

1.65

9.09

1.6

1.4

0.24

g/l

0.10

171

1021

Ptosis of eyelid

157

934

1.71

9.00

1.7

1.5

0.24

g/l

0.22

145

889

Artificial joint operation, meniscal resection

1435

8032

1.19

8.94

1.6

0.24

g/l

1.75

1359

7594

Focal epilepsy

324

2266

1.44

8.93

2.2

1.7

0.23

g/l

0.73

306

2148

Benign neoplasm: Adrenal gland

119

656

1.85

8.93

1.4

1.6

0.26

0.24

g/l

1.65

106

622

Amiodarone users

136

781

1.77

8.86

1.4

0.23

0.24

g/l

0.38

126

739

931

6761

1.24

8.85

1.6

1.7

0.24

g/l

1.22

873

6444

Ulcer of oesophagus

515

1.96

8.85

1.4

0.25

0.24

g/l

0.51

484

Female infertility

583

2741

1.32

8.85

1.8

0.23

g/l

0.31

561

2591

Myasthenia gravis

152

2.90

8.84

2.0

1.4

0.21

0.24

g/l

1.57

145

Bell's palsy

183

1138

1.63

8.83

1.5

1.6

0.25

0.24

g/l

1.75

168

1072

Benign neoplasm: Descending colon

516

1.96

8.83

1.5

0.24

0.23

g/l

0.51

487

Faecal incontinence

136

782

1.77

8.83

2.3

1.6

0.22

0.23

g/l

1.09

121

740

Pleural plaque

112

607

1.87

8.81

1.7

1.3

0.24

g/l

0.22

105

576

Hernia of abdominal wall

670

5245

1.29

8.80

1.5

1.6

0.24

g/l

0.72

619

4978

Atrophic disorders of skin

219

1422

1.56

8.78

1.9

1.6

0.24

0.23

g/l

0.55

209

1338

Thyrotoxicosis with diffuse goitre

239

1583

1.53

8.75

1.6

1.8

0.23

g/l

0.45

221

1505

Overexertion and strenuous or repetitive movements

164

995

1.67

8.75

1.6

0.25

0.24

g/l

1.53

157

945

Emotionally unstable personality disorder

233

1536

1.54

8.74

1.6

2.0

0.24

0.23

g/l

0.82

218

1460

Strabismus

438

3231

1.37

8.74

1.7

1.8

0.23

g/l

0.33

407

3079

Superficial injury of wrist and hand

326

2295

1.44

8.71

1.6

1.8

0.23

g/l

0.44

309

2184

Other spirochaetal diseases

398

2900

1.39

8.70

1.8

1.7

0.23

0.24

g/l

1.34

368

2738

Sensorineural hearing loss

1133

6552

1.22

8.67

1.6

0.23

0.24

g/l

2.45

1064

6192

Abrasion of teeth

438

2368

1.37

8.65

2.0

1.7

0.22

0.23

g/l

1.59

416

2252

Female infertility, cervigal, vaginal, other or unspecified origin

525

2651

1.34

8.64

1.7

1.8

0.23

g/l

0.15

502

2508

Golimumab

318

2.24

8.64

1.7

0.22

0.24

g/l

1.31

300

Lymphoid leukaemia

444

2.03

8.63

1.9

1.4

0.25

0.24

g/l

0.56

428

Fracture at wrist and hand level

527

4006

1.32

8.62

1.7

0.23

g/l

1.08

499

3812

Other problems related to primary support group, including family circumstances

228

1463

1.54

8.60

2.1

1.9

0.22

g/l

0.21

219

1398

Unspecified misadventure during surgical and medical care

466

2.00

8.58

1.6

1.5

0.24

g/l

0.11

442

L01XX Other antineoplastic agents

425

2.04

8.56

1.3

1.6

0.22

0.24

g/l

0.76

405

Other and unspecified types of non-Hodgkin lymphoma, hilmo

332

2.20

8.55

1.8

1.5

0.23

0.24

g/l

0.36

315

Tinnitus

354

2540

1.41

8.50

1.8

1.6

0.23

0.24

g/l

0.76

339

2404

Benign neoplasm: Adrenal gland

119

667

1.82

8.48

1.4

1.6

0.26

0.24

g/l

1.50

106

638

Benign neoplasm: Rectum, anus and anal canal

267

1820

1.48

8.48

1.4

1.5

0.24

g/l

0.09

252

1721

Bacterial, viral and other infectious agents

146

867

1.71

8.47

1.7

1.6

0.23

0.24

g/l

0.84

140

820

Drug-induced Cushing's syndrome

11.70

8.44

1.0

1.1

0.26

0.27

g/l

—

Fentanyl

121

681

1.80

8.41

1.4

1.5

0.24

0.23

g/l

0.16

112

646

Carbimazole or st.post thyroidectomy, condition for graves disease

342

2447

1.41

8.38

1.6

1.8

0.24

0.23

g/l

0.58

316

2320

Benign neoplasm: Descending colon

526

1.92

8.36

1.5

1.4

0.24

g/l

0.06

501

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1023

6876

1.22

8.32

2.2

1.8

0.23

g/l

1.47

971

6514

Aortic arch syndrome [Takayasu]

8.33

8.28

1.8

1.1

0.22

0.24

g/l

0.33

Other predominantly sexually transmitted diseases, not elsewhere classified

314

2221

1.43

8.23

2.5

1.9

0.22

0.23

g/l

2.42

296

2115

Ulcerative rectosigmoiditis

141

837

1.71

8.21

1.5

1.7

0.22

0.24

g/l

1.53

133

793

Benign neoplasm: Small intestine

338

2.16

8.20

1.4

1.5

0.24

g/l

0.10

321

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Complement C4 [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS